0001387131-19-006135.txt : 20190814 0001387131-19-006135.hdr.sgml : 20190814 20190814160648 ACCESSION NUMBER: 0001387131-19-006135 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NANOPHASE TECHNOLOGIES Corp CENTRAL INDEX KEY: 0000883107 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRIMARY METAL PRODUCTS [3390] IRS NUMBER: 363687863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-22333 FILM NUMBER: 191026311 BUSINESS ADDRESS: STREET 1: 1319 MARQUETTE DRIVE CITY: ROMEOVILLE STATE: IL ZIP: 60446 BUSINESS PHONE: 6303231200 MAIL ADDRESS: STREET 1: 1319 MARQUETTE DRIVE CITY: ROMEOVILLE STATE: IL ZIP: 60446 FORMER COMPANY: FORMER CONFORMED NAME: NANOPHASE TECHNOLOGIES CORPORATION DATE OF NAME CHANGE: 19970305 10-Q 1 nanx-10q_063019.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended: June 30, 2019

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) of the

Securities Exchange Act of 1934

For the transition period from to

Commission File Number: 000-22333

Nanophase Technologies Corporation

(Exact name of registrant as specified in its charter)

Delaware	36-3687863
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

1319 Marquette Drive, Romeoville, Illinois 60446

(Address of principal executive offices, and zip code)

Registrant’s telephone number, including area code: (630) 771-6708

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $.01 par value	NANX	OTCQB

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “accelerated filer”, “large accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐

Non-accelerated filer ☐	Smaller reporting company ☑

	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of August 14, 2019, there were 38,136,792 shares outstanding of common stock, par value $.01, of the registrant.

NANOPHASE TECHNOLOGIES CORPORATION

QUARTER ENDED JUNE 30, 2019

INDEX


		Page

PART I - FINANCIAL INFORMATION		1
Item 1.	Unaudited Consolidated Condensed Financial Statements	1
	Balance Sheets (Unaudited Consolidated Condensed) as of June 30, 2019 and December 31, 2018	1
	Statements of Operations (Unaudited Consolidated Condensed) for the three and six months ended June 30, 2019 and 2018	2
	Statements of Stockholders Equity (Unaudited Consolidated Condensed) for the three and six months ended June 30, 2019 and 2018	3
	Statements of Cash Flows (Unaudited Consolidated Condensed) for the six months ended June 30, 2019 and 2018	4
	Notes to Unaudited Consolidated Condensed Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4.	Controls and Procedures	18

PART II - OTHER INFORMATION		18
Item 1.	Legal Proceedings	18
Item 1A.	Risk Factors	18
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3.	Defaults Upon Senior Securities	20
Item 4.	Mine Safety Disclosures	20
Item 5.	Other Information	20
Item 6.	Exhibits	21

SIGNATURES		22

PART I - FINANCIAL INFORMATION

Item 1.

Financial Statements

NANOPHASE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEETS

(Unaudited Consolidated Condensed)

	(in thousands except share and per share data)
	June 30,			December 31,
	2019			2018
ASSETS
Current assets:
Cash	$	1,015		$	1,345
Trade accounts receivable, less allowance for doubtful accounts of $9 on June 30, 2019 and December 31, 2018, respectively		1,652			829
Inventories, net		2,093			2,242
Prepaid expenses and other current assets		351			273
Total current assets		5,111			4,689

Equipment and leasehold improvements, net		2,127			1,865
Operating lease right-of-use assets		2,059			—
Other assets, net		14			15
	$	9,311		$	6,569
LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Line of credit, related party	$	1,246		$	832
Current portion of finance lease obligations		227			218
Current portion of operating lease obligations		329			—
Accounts payable		1,423			1,608
Accrued expenses		925			979
Total current liabilities		4,150			3,637

Long-term portion of finance lease obligations		390			506
Long-term portion of operating lease obligations		2,038			—
Long-term loan, related party		500			500
Long-term deferred rent		—			344
Asset retirement obligations		202			198
Total long-term liabilities		3,130			1,548
Contingent Liabilities:
Stockholders’ equity:
Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding		—			—
Common stock, $.01 par value, 42,000,000 shares authorized; 38,100,792 shares issued and outstanding on June 30, 2019 and 33,911,792 December 31, 2018		381			339
Additional paid-in capital		100,560			98,795
Accumulated deficit		(98,910	)		(97,750	)
Total stockholders’ equity		2,031			1,384
	$	9,311		$	6,569

See Notes to Consolidated Financial Statements.

NANOPHASE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited Consolidated Condensed)

(in thousands except share and per share data)

	Three months ended June 30,					Six months ended June 30,
	2019			2018		2019			2018
Revenue:
Product revenue	$	3,257		$	4,043	$	6,754		$	6,910
Other revenue		37			73		295			104
Total revenue		3,294			4,116		7,049			7,014

Operating expense:
Cost of revenue		2,462			2,711		5,333			5,199
Gross profit		832			1,405		1,716			1,815

Research and development expense		485			538		962			1,096
Selling, general and administrative expense		944			770		1,821			1,535
(Loss)/income from operations		(597	)		97		(1,067	)		(816	)
Interest expense		50			9		93			20
Other, net		—			—		—			—
(Loss)/income before provision for income taxes		(647	)		88		(1,160	)		(836	)
Provision for income taxes		—			—		—			—
Net (loss)/income	$	(647	)	$	88	$	(1,160	)	$	(836	)

Net (loss)/income per basic shares	$	(0.02	)	$	0.00	$	(0.03	)	$	(0.02	)
Weighted average number of basic common shares outstanding		36,136,759			33,847,793		35,030,422			33,847,793
Net (loss)/income per diluted share	$	(0.02	)	$	0.00	$	(0.03	)	$	(0.02	)
Weighted average number of diluted common shares outstanding		36,136,759			34,909,793		35,030,422			33,847,793

See Notes to Consolidated Financial Statements.

NANOPHASE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY

(Unaudited Consolidated Condensed)

(In thousands except share data)

	Preferred Stock				Common Stock				Additional		Accumulated
Description	Shares		Amount		Shares		Amount		Paid-in-Capital		Deficit			Total
Balance on December 31, 2017		—	$	—		33,847,793	$	338	$	98,563	$	(95,669	)	$	3,232

Stock-based compensation		—		—		—		—		43		—			43

Net loss		—		—		—		—		—		(924	)		(924	)

Balance on March 31, 2018		—	$	—		33,847,793	$	338	$	98,606	$	(96,593	)	$	2,351

Stock-based compensation		—		—		—		—		45		—			45

Net loss		—		—		—		—		—		88			88

Balance on June 30, 2018		—	$	—		33,847,793	$	338	$	98,651	$	(96,505	)	$	2,484

Balance on December 31, 2018		—	$	—		33,911,792	$	339	$	98,795	$	(97,750	)	$	1,384

Stock-based compensation		—		—		—		—		57		—			57

Issuance of Common Stock		—		—		—		—		—		—			—

Net loss		—		—		—		—		—		(513	)		(513	)

Balance on March 31, 2019		—	$	—		33,911,792	$	339	$	98,852	$	(98,263	)	$	928

Stock option exercises		—		—		36,000		—		16		—			16

Stock-based compensation		—		—		—		—		58		—			58

Issuance of Common Stock		—		—		4,189,000		42		1,634		—			1,676

Net loss		—		—		—		—		—		(647	)		(647	)

Balance on June 30, 2019		—	$	—		38,136,792	$	381	$	100,560	$	(98,910	)	$	2,031

See Notes to Consolidated Financial Statements.

NANOPHASE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited Consolidated Condensed)

	Six months ended June 30, 2019
	2019			2018
	(in thousands)
Operating activities:
Net loss		(1,160	)		(836	)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization		155			166
Loss on disposal of equipment and leasehold improvements		16			—
Share-based compensation		115			88

Changes in assets and liabilities related to operations:
Trade accounts receivable		(823	)		(313	)
Inventories		149			(264	)
Prepaid expenses and other assets		(78	)		(109	)
Accounts payable		(224	)		563
Accrued expenses		(54	)		102
Other long-term assets and liabilities		(36	)		—
Net cash used in operating activities		(1,940	)		(603	)

Investing activities:
Acquisition of equipment and leasehold improvements		(389	)		(132	)
Net cash used in investing activities		(389	)		(132	)

Financing activities:
Principal payment on finance leases		(107	)		(79	)
Proceeds from line of credit, bank		500			700
Payments to the line of credit, bank		(500	)		(500	)
Proceeds from line of credit, related party		5,846			—
Payments to line of credit, related party		(5,432	)		—
Proceeds from issuance of common stock		1,676			—
Proceeds from stock option exercises		16			—
Net cash provided by financing activities		1,999			121
Decrease in cash and cash equivalents		(330	)		(614	)
Cash and cash equivalents at beginning of period		1,345			1,955
Cash and cash equivalents at end of period	$	1,015		$	1,341

Supplemental cash flow information:
Interest paid	$	86		$	20

Supplemental non-cash investing and financing activities:
Accounts payable incurred for the purchase of equipment and leasehold improvements	$	39		$	8
Non-cash purchases of property and equipment	$	—		$	45

See Notes to Consolidated Financial Statements.

NANOPHASE TECHNOLOGIES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited Consolidated Condensed)

(in thousands, except share and per share data or as otherwise noted herein)

(1) Basis of Presentation

The accompanying unaudited consolidated condensed interim financial statements of Nanophase Technologies Corporation (“Nanophase”, “Company”, “we”, “our”, or “us”) reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management, are necessary for a fair presentation of our financial position and operating results for the interim periods presented. All statements include the results from both Nanophase and our wholly-owned subsidiary, Solesence, LLC (“Solésence,” or our “Solésence® subsidiary”). Operating results for the three and six months ended June 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019.

These financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December 31, 2018, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the Securities and Exchange Commission.

(2) Going Concern / Liquidity

We believe that cash from operations, cash on hand, cash from our May 13, 2019 financing, in addition to unused borrowing capacity, should be adequate to fund our operating plans through 2019, but this is dependent on several things over which we have limited control. Our largest customer made up 74% of our 2018 revenue and we expect a material reduction in orders from them in 2019, which has limited our flexibility and required us to make cash management a top priority. We also expect growth in our Solésence® business, which we view as a critical strategic undertaking, and may require additional investment in working capital. Our current plan is to continue to invest in Solésence®-related operating expenses and capital equipment. Given the uncertainties relating to our largest customer, as well as our growth strategy for Solésence®, it is possible that we may need to seek additional funding to address working capital demands within the next twelve months. We believe that we will be able to secure additional financing if needed, but we do not have any additional financing commitments in place as of today. However, we may not be able to secure additional financing in a timely manner under commercially reasonable terms, or at all. If we are unable to secure additional financing, we would need to delay capital expenditures related to our Solésence® growth strategy, which could impede growth in 2019 and 2020.

These circumstances raise significant doubt as to the Company’s ability to operate as a going concern under U.S. GAAP. The accompanying financial statements have been prepared on a going concern basis in accordance with U.S. GAAP. As such, no adjustments have been made to the unaudited condensed consolidated financial statements for the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue operating as a going concern.

(3) Summary of Significant Accounting Policies

Recently Adopted Financial Accounting Standards

On January 1, 2019, the Company adopted Accounting Standards Update (“ASU”) No. 2016-02, Leases, ASU No. 2018-10, Codification Improvements to Topic 842 (Leases) and ASU No. 2018-11, Targeted Improvements to Topic 842 (Leases). The guidance is intended to increase transparency and comparability among companies for leasing transactions, including a requirement for companies that lease assets to recognize on their balance sheets the assets and liabilities for the rights and obligations created by those leases. The guidance also provides for disclosures that allow the users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.

The Company adopted the guidance on January 1, 2019 using the modified retrospective method without restatement of comparative periods. As such, periods prior to the date of adoption are presented in accordance with ASC 840 - Leases. The Company utilized the available practical expedient that allowed for the Company to not reassess whether existing contracts contain a lease under the new definition of a lease, lease classification for existing leases and whether previously capitalized initial direct costs would qualify for capitalization under the new guidance.

The adoption of this guidance had a material impact on the Consolidated Condensed Balance Sheet as of June 30, 2019 due to the recognition of equal right-of-use assets and lease liabilities for the Company’s portfolio of operating leases. The right-of-use asset balance was then adjusted by the reclassification of pre-existing accrued rent balances from other line items within the Consolidated Condensed Balance Sheet. The adoption had an immaterial impact to the Consolidated Condensed Statement of Cash Flows and to the Consolidated Condensed Statement of Operations for the three and six months ended June 30, 2019. The adoption had no impact to the Consolidated Condensed Statement of Changes in Stockholders’ Equity for the three and six months ended June 30, 2019. Additional information and disclosures required by the new standard are contained in Note 10, Leases.

(4) Description of Business

Nanophase is a skin and sun care focused company that offers engineered materials, formulation development and commercial manufacturing with an integrated family of technologies. We look at our products in three major product categories; Personal Care Ingredients, including sunscreens as active ingredients; Solésence, including full formulations of skin care products, marketed and sold by our wholly-owned subsidiary, Solesence, LLC (“Solésence,” or our “Solésence® subsidiary”); and Advanced Materials, including architectural and industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, and a variety of surface finishing technologies (polishing).

Although our primary strategic focus has been the North American market, we currently sell material to customers overseas and have been working to expand our reach within foreign markets. The Company was incorporated in Illinois on November 25, 1989 and became a Delaware corporation during November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.

While product sales comprise the majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected to drive the long-term growth of the business. For this reason, we classify such revenue as “other revenue” in our Consolidated Condensed Statements of Operations, as it does not represent revenue directly from the sale of our products.

(5) Revenues

Revenues are recognized at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods.

Customers deposits, deferred revenue and other receipts are deferred and recognized when the revenue is realized and earned. Cash payments to customers are classified as reductions of revenue in the Company’s Consolidated Condensed Statement of Operations.

(6) Earnings Per Share

Earnings (Loss) Per Share is computed using the Treasury Stock Method. Options to purchase approximately 409,000 shares of common stock that were outstanding for the three months ended June 30, 2019, which were not included in the computation of diluted earnings (loss) per share as the impact of such shares would be anti-dilutive. For the three months ended June 30, 2018, options to purchase approximately 1,062,000 shares of common stock were outstanding and were included in the computation of diluted earnings (loss) per share for the three months ended June 30. This had a $0.00 impact per diluted share for the three months ended June 30, 2018. Options to purchase approximately 671,000 and 681,000 shares of common stock that were outstanding as of June 30, 2019 and June 30, 2018, respectively, were not included in the computation of diluted earnings (loss) per share for the six months ended June 30, 2019 and June 30, 2018, as the impact of such shares would be anti-dilutive.

(7) Financial Instruments

We follow the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.

Our financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with the promissory note with no related borrowings described in Note 8, and any borrowings on the working capital line of credit from Libertyville Bank and Trust and any borrowings under the Master Agreement from Beachcorp, LLC described below in Note 8. The fair values of all financial instruments were not materially different from their carrying values. There were no financial assets or liabilities adjusted to fair value on June 30, 2019 or December 31, 2018.

(8) Notes and Line of Credit

During July 2014 we entered into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our obligations under our facility lease agreement. No borrowings have been incurred under this promissory note. Should any borrowings occur in the future, the interest rate would be the prime rate plus 1%, with the bank having the right to “set off” or apply unpaid balances against our checking account if we fail to meet our obligations under any borrowings under the note. It is our intention to renew this note annually, for as long as we need to do so pursuant to the terms of our facility lease agreement. This note was renewed through July 1, 2020. Because there were no amounts outstanding on the note at any time during 2019 or 2018, we have recorded no related liability on our balance sheet.

On March 22, 2019, we executed a New Business Loan Agreement, dated as of March 4, 2019, with Libertyville Bank and Trust Company, a Wintrust Community Bank (“Libertyville”), our primary bank, which replaces the Line of Credit Agreement with Libertyville having a maturity date of March 4, 2019. Under the New Business Loan Agreement, Libertyville will provide a maximum of (i) $500 or (ii) two times the sum of (a) 75% our eligible accounts receivables and (b) our cash deposited with Libertyville, whichever is less, of revolving credit to us, collateralized by a senior priority lien on our accounts receivable, inventory, equipment, general intangibles and fixtures. Interest is payable monthly on any advances at a floating interest rate of the prime rate at the time plus 1%. We must have $500 in cash, inclusive of the borrowed amount, at Libertyville on the date of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be repaid in full within five business days of the advance. Amounts due under the Line of Credit Agreement must be paid in full on April 4, 2020. There was no outstanding balance on this loan at June 30, 2019 or December 31, 2018.

On November 16, 2018, we entered into a Business Loan Agreement (the “Master Agreement”) with Beachcorp, LLC. Beachcorp, LLC is managed by Bradford T. Whitmore, who, together with his affiliates Grace Brothers, Ltd. and Grace Investments, Ltd., beneficially owned approximately 53% of our common stock as of May 13, 2019, pursuant to our 2019 financing. The Master Agreement relates to two loan facilities, each evidenced by separate promissory notes, each dated November 16, 2018: a term loan to the Company of up to $500 to be disbursed in a single advance (the “Term Loan”) with a fixed annual interest rate of 8.25%, payable quarterly, accruing from the date of such advance and with principal due on December 31, 2020; and an asset-based revolving loan facility for the Company of up to $2,000 (the “Revolver Facility”), with floating interest accruing at the prime rate plus 3% (8.25% minimum) per year, with a borrowing base consisting of qualified accounts receivable of the Company, and with all principal and accrued interest due March 31, 2020. The Term Loan and Revolver Facility are secured by all the unencumbered assets of the Company and subordinated to Libertyville’s secured interest under the New Business Loan Agreement. The Master Agreement substantially restricts the Company’s ability to incur additional indebtedness during the terms of both the Term Loan and the Revolver Facility. On June 30, 2019, the balance on the term loan was $500 and the balance on the Revolver Facility was $1,246. For the three months and six months ended June 30, 2019, interest expense was $50 and $93, respectively, compared to the same periods in 2018 of $9 and $20, respectively. For the six months ended June 30, 2019, $7 was accrued and $86 paid. As Beachcorp, LLC is an affiliate of one of our shareholders, $59 is interest to be paid to a related party. On June 30, 2019 borrowings were within the credit agreement limit with an additional $345 available. The balance of borrowing base, loan amount, and any excess payments required over the available borrowing base will change as frequently as daily, given the operational nature of the elements of the Revolver Facility.

(9) Inventories

Inventories consist of the following:

	June 30, 2019			December 31, 2018

Raw materials	$	1,118		$	1,086
Finished goods		1,041			1,243
		2,159			2,329
Allowance for excess inventory quantities		(66	)		(87	)
	$	2,093		$	2,242

(10) Leases

The Company’s operating lease portfolio is comprised of operating leases for office, warehouse space and equipment. Certain of the Company’s leases include one or more options to renew or terminate the lease at the Company’s discretion. The Company regularly evaluates the renewal and termination options and when they are reasonably certain of exercise, includes the renewal or termination option in our lease term.

The adoption of Topic 842 resulted in the Company recognizing operating lease liabilities totaling $2,556 with a corresponding right-of-use (“ROU”) asset of $2,212 based on the present value of the minimum rental payments of such leases. The variance between the ROU asset balance and the lease liability is deferred rent liability that existed prior to the adoption of the ASC 842 and was offset against the ROU asset balance during the adoption. As of June 30, 2019, the ROU asset had a balance of $2,059 which is included in the “Operating lease right-of-use assets” line item of these condensed consolidated financial statements and current and non-current lease liabilities related to the ROU asset of $329 and $2,038 respectively, and are included in the “Current portion of operating lease obligations” and “Long-term portion of operating lease obligations” line items of these condensed consolidated financial statements. The discount rates used for leases accounted for under ASC 842 are based on an interest rate yield curve developed for the leases in the Company’s portfolio.

The office leases contain variable lease payments which consist primarily of rent escalations based on an established index or rate and taxes, insurance, and common area or other maintenance costs, which are paid based on actual costs incurred by the lessor. The Company has elected to utilize the available practical expedient to not separate lease and non-lease components.

Quantitative information regarding the Company’s leases is as follows:

	Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Components of lease cost
Finance lease cost components:
Amortization of finance lease assets	$	17	$	34
Interest on finance lease liabilities		14		30
Total finance lease costs		31		64
Operating lease cost components:
Operating lease cost		123		246
Variable lease cost		27		54
Short-term lease cost		30		52
Total operating lease costs		180		352

Total lease cost	$	211	$	416

Supplemental cash flow information related to leases is as follows for the six months ended June 30, 2019:

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflow from operating leases	$	336

Weighted-average remaining lease term-finance leases (in years)		2.4
Weighted-average remaining lease term-operating leases (in years)		3.5
Weighted-average discount rate-finance leases		9.1	%
Weighted-average discount rate-operating leases		14.4	%

The future maturities of the Company’s finance and operating leases as of June 30, 2019 is as follows:

	Finance Leases			Operating Leases			Total
2019	$	137		$	338		$	475
2020		255			616			871
2021		196			618			814
2022		109			632			741
2023		5			642			647
2024 and thereafter		—			580			580
Total payments	$	702		$	3,426		$	4,128
Less amounts representing interest		(85	)		(1,059	)		(1,144	)
Total minimum payments required:	$	617		$	2,367		$	2,984

(11) Share-Based Compensation

We follow FASB ASC Topic 718, Compensation – Stock Compensation, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $58 and $115 for the three and six months ended June 30, 2019, respectively, compared to $43 and $88 for the three and six months ended June 30, 2018, respectively.

As of June 30, 2019, there was approximately $486 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.0 years.

Stock Options and Stock Grants

During the six months ended June 30, 2019, 36,000 stock options were exercised for $16, while no stock options were exercised for the same period in 2018. During the six months ended June 30, 2019, 547,500 stock options were granted, compared to 570,500 stock options granted during the same period in 2018. During the six months ended June 30, 2019, 130,500 stock options expired compared to 188,504 for the same period in 2018. For the six months ended June 30, 2019, 48,600 stock options were forfeited compared to no stock options being forfeited for the same period in 2018. We had 3,747,400 stock options outstanding at a weighted average exercise price of $0.64 on June 30, 2019, compared to 3,415,000 stock options outstanding at a weighted average exercise price of $0.67 on December 31, 2018.

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month and six month periods presented:

For the three months ended	June 30, 2019			June 30, 2018
Weighted-average risk-free interest rates:		2.5	%		2.9	%
Dividend yield:		—			—
Weighted-average expected life of the option:		7 years			7 years
Weighted-average expected stock price volatility:		94	%		94	%
Weighted-average fair value of the options granted:	$	0.67		$	0.66

For the six months ended	June 30, 2019			June 30, 2018
Weighted-average risk-free interest rates:		2.5	%		2.9	%
Dividend yield:		—			—
Weighted-average expected life of the option:		7 years			7 years
Weighted-average expected stock price volatility:		94	%		94	%
Weighted-average fair value of the options granted:	$	0.64		$	0.64

As of June 30, 2019, we did not have any unvested restricted stock or performance shares outstanding.

(12) Significant Customers and Contingencies

Revenue from three customers constituted approximately 65%, 5% and 4%, respectively, of our total revenue for the three months ended June 30, 2019. For the six months ended June 30, 2019, revenue from the same three customers was approximately 59%, 12% and 3%, respectively. Amounts included in accounts receivable on June 30, 2019 relating to these three customers were approximately $843, $212 and $93, respectively. Revenue from these three customers constituted approximately 66%, 10% and 4%, respectively, for the three months ended June 30, 2018. For the six months ended June 30, 2018, revenue from the same three customers was approximately 73%, 6% and 3%, respectively. Amounts included in accounts receivable on June 30, 2018 relating to these three customers were approximately $927, $54 and $76, respectively. The loss of one of these significant customers, a significant decrease in revenue from one or more of these customers, or the failure to attract new customers could have a material adverse effect on our business, results of operations and financial condition.

We currently have exclusive supply agreements with BASF Corporation (“BASF”), our largest customer, that have contingencies outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended to provide capacity sufficient to meet the customer’s production needs. This outcome may occur if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition covenants in one of our supply agreements with BASF “trigger” a technology transfer right (license and equipment sale at BASF’s option) in the event (a) that earnings for the twelve-month period ending with our most recently published quarterly financial statements are less than zero and a minimum of $1 million in total of certain assets of which at least $500 must be in cash, cash equivalents and certain investments, with the balance being composed of certain inventory and receivables, is not maintained or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. There are certain minimum finished goods inventory requirements with the 2019 amendment to the supply agreement. This agreement also requires Nanophase to maintain certain finished goods inventory levels as “safety stock,” beginning in the first quarter of 2019, and increasing through the third quarter of 2019 to a negotiated level based on agreed demand metrics, in order to maintain the $500 non-cash component discussed above. After September 30, 2019, should our safety stock fall below the prescribed amount of material, the quarter-end cash requirement would revert to $1,000 in cash, cash equivalents, and certain investments. The safety stock requirement may be adjusted upon mutual agreement.

Our supply agreements with BASF also “trigger” a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment’s net book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the equipment’s net book value, depending on the equipment and related products.

We believe that we should have sufficient cash and credit availability (See the description of our New Line of Credit Agreement with Libertyville and the Master Agreement with Beachcorp, LLC (described in Note 8) to operate our business during 2019, but this is dependent on several things over which we have limited control. If a triggering event were to occur and BASF elected to proceed with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities. We believe that our employees are a critical component of our success and it could be difficult to replace them quickly. Given the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.

We expect to expend resources on research, development and product testing, and in expanding current capacity or capability for new business. In addition, we may incur significant costs in preparing, filing, prosecuting, maintaining and enforcing our patents and other proprietary rights. We may need additional financing if we were to lose an existing customer or suffer a significant decrease in revenue from one or more of our customers or because of currently unknown capital requirements, new regulatory requirements or the need to meet the cash requirements discussed above to avoid a triggering event under our BASF agreement. Given our expected growth in our Solésence® business, we may also have temporary working capital demands that we cannot fund with existing capital, while remaining in compliance with the covenants included in our BASF agreement described above. If necessary, we may seek funding through public or private financing and through contracts with governmental entities or other companies. Additional financing may not be available on acceptable terms or at all, and any such additional financing could be dilutive to our shareholders. If we are unable to obtain adequate funds, we may be required to delay, scale-back or eliminate some of our manufacturing and marketing operations or we may need to obtain funds through arrangements on less favorable terms. Such circumstances could raise doubt as to our ability to continue as a going concern. If we obtain funding on unfavorable terms, we may be required to relinquish rights to some of our intellectual property.

(13) Business Segmentation and Geographical Distribution

Revenue from international sources approximated $243 and $700 for the three and six months ended June 30, 2019, respectively, compared to $164 and $183 for the three and six months ended June 30, 2018, respectively. All of this revenue was product revenue.

Our Operations comprise a single business segment and all our long-lived assets are located within the United States. We categorize our revenue stream into three main product categories, Personal Care Ingredients, Advanced Materials and Solésence®. The revenues for the three months and six months ended June 30, 2019 and 2018, by category, are as follows:

	For the three months ended				For the six months ended
	June 30				June 30
Product Category	2019		2018		2019		2018
Personal Care Ingredients	$	2,151	$	2,923	$	4,160	$	5,228
Advanced Materials		750		742		1,600		1,274
Solésence^®		393		451		1,289		512
Total Sales	$	3,294	$	4,116	$	7,049	$	7,014

(14) Subsequent Events

On July 31, 2019, we entered into a Joint Development Agreement, with an initial term of ten years, with Sumitomo Corporation of Americas (“SCOA”) to jointly develop certain coated materials for the use in the personal care market. In return for the Company’s exclusive efforts on SCOA’s behalf, SCOA has agreed to pay a commitment fee of $250 and two subsequent payments, $125 each, in accordance with product development milestones expected to be earned over the next several years. Additionally, a royalty payment from the sale of the Joint Development Product will be paid to the Company.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

(Dollars are presented in thousands except per share data or unless otherwise stated)

Overview

Nanophase is an advanced materials and applications developer and commercial manufacturer with an integrated family of materials technologies. We produce engineered nano and “non-nano” materials for use in a variety of diverse markets: personal care including sunscreens as active ingredients and in fully formulated cosmetics of our own design, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy (including solar control) and a variety of surface finishing technologies (polishing) applications, including optics. Finally, we have expanded our offerings beyond active ingredients to include targeted full formulations of skin care products, marketed and sold by our wholly-owned subsidiary, Solesence, LLC (“Solésence,” or our “Solésence® subsidiary”).

We target markets in which we believe practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers, and our Solésence® solutions to cosmetics and skin care brands. Recently developed technologies have made certain new products possible and opened potential new markets. For example, we have applied our skills at producing precisely defined nanomaterials to now create and sell larger, “non-nano” material products. Our focus is on customer need where we believe we have an advantage, as opposed to finding uses for one particular technology. We expect growth in end-user (manufacturing customers, including customers of our customers) adoption in 2019 and beyond. Our initiatives in targeted market areas are progressing at differing rates of speed, but we have been broadly moving through testing and development cycles, and in a number of cases believe we are approaching first revenue or next stage revenue with particular customers in the industries referenced above. For example, during 2015 we were granted a patent on a new type of particle surface treatment (coating), which became the cornerstone of our new product development in personal care, with first revenue recognized during 2016. In addition, through the creation of our Solésence® subsidiary, we use this particle surface treatment to manufacture and sell fully developed solutions to targeted customers in the cosmetics and skin care industry, in addition to the additives we have traditionally sold in the personal care area. During 2015 and 2016 we developed and began to sell solutions in the energy management (particularly solar control) industry. We believe that the products that we have designed for this industry remain valuable to the market, although we are currently focusing the greatest part of our business development efforts on building and expanding our Solésence® brand and product suite. We believe that successful introduction of our finished skin care products and materials with manufacturers may lead to follow-on orders for other finished products and materials in their applications. We expect that we will both work more deeply with current customers and attract additional customers, which should help us achieve growth in these markets in 2019 and beyond.

Results of Operations

Total revenue decreased to $3,293 for the three months ended June 30, 2019, compared to $4,116 for the same period in 2018. Total revenue increased to $7,049 for the six months ended June 30, 2019 from $7,014 for the same period 2018. A substantial majority of our revenue for both periods was from our largest customers, in particular, sales to our largest customer in personal care and sunscreen applications. Revenue from our top three customers was approximately 65%, 5% and 4%, respectively, of our total revenue for the three months ended June 30, 2019 and approximately 59%, 12% and 3%, respectively, for the six months ended June 30, 2019. Revenue from these three customers constituted approximately 66%, 10% and 4%, respectively for the three months ended June 30, 2018 and approximately 73%, 6% and 3%, respectively, for the six months ended June 30, 2019. Product revenue, the primary component of our total revenue, decreased to $3,257 for the three months ended June 30, 2018, compared to $4,043 for the same period in 2018. The decrease was primarily due to reduced order flow from several of our larger customers, including our largest customer in personal care. Product revenue decreased to $6,754 for the six months ended June 30, 2019, compared to $6,910 for the same period in 2018. While Solésence® product revenue increased approximately150% for the six months ended June 30, 2019 compared to the same period for 2018, the decrease in product revenue is attributed to order flow from our largest personal care customer.

Other revenue decreased to $36 for the three months ended June 30, 2019, compared to $73 for the same period in 2018. Other revenue increased to $295 for the six months ended June 30, 2019, compared to $104 for the same period in 2018. Other revenue is typically comprised of royalties and shipping costs paid by customers. For the six months ended June 30, 2019, other revenue included a unique bulk buyout of $211 in Q1 of 2019.

Cost of revenue generally includes costs associated with commercial production and customer development arrangements. Cost of revenue decreased to $2,462 for the three months ended June 30, 2019, compared to $2,711 for the same period in 2018. The decrease in cost of revenue was primarily driven by decreased volume coupled with price inflation on materials and manufacturing inefficiencies related to Solésence® product launches. While we typically pass through costs to our customers, we sometimes cannot pass through 100% of pricing increases on raw materials. Even with pass throughs, our gross margin percentage is negatively impacted by higher material costs. We expect to continue new advanced material development relating to personal care ingredients and for our formulated Solésence® products during 2019 and beyond. At current revenue levels, we have generated a positive gross margin, though margins have been impeded by not having enough revenue to efficiently absorb manufacturing overhead. We believe that our current fixed manufacturing cost structure is sufficient to support higher levels of revenue volume. The extent to which margins may grow, as a percentage of total revenue, will be dependent upon revenue mix, revenue volume, our ability to manage costs and pass commodity market-driven raw materials increases on to customers, and the speed and efficiency with which we are able to scale up production for our Solésence® products. We expect that product revenue volume increases would result in our fixed manufacturing costs being more efficiently absorbed, which should lead to increased margins. We expect to continue to focus on reducing controllable variable product manufacturing costs, with potential variability related to the commodity metals markets, but may or may not realize absolute dollar gross margin growth through 2019 and beyond, dependent upon the factors discussed above.

Research and development expense, which includes all expenses relating to the technology and advanced engineering groups, primarily consists of costs associated with the development or acquisition of new product applications, and finished product formulations for our Solésence® business. As an example, we have been, and continue to be, engaged in product development work for our new fully-formulated finished skincare products marketed through Solésence®. Much of this work has led to several new products and additional potential new products. We are also engaged in a series of in-vitro, ex-vivo, and in-vivo tests to determine the efficacy of our Solésence® products, as well as to provide our customers with support for a consumer claims set. We are not certain when or if any significant revenue will be generated from the production of the materials described above.

Research and development expense decreased to $485 for the three months ended June 30, 2019, compared to $538 for the same period in 2018. For the six months ended June 30, 2019 research and development expense decreased to $962, compared to $1,096 for the same period in 2018. The primary reasons for this decrease were timing related to outside product testing and evaluation costs related to our Solésence® products. We expect quarterly research and development expense to increase during the remainder of 2019.

Selling, general and administrative expense increased to $944 for the three months ended June 30, 2019, compared to $770 for the same period in 2018. For the six months ended June 30, 2019, selling, general and administrative expense increased to $1,821, compared to $1,535 for the same period in 2018. Expenses associated with launching the Solésence® brand contributed to the increase. We expect selling, general and administrative expense to remain at current levels during the remainder of 2019.

Inflation

We believe inflation has not had a material effect on our operations or financial position. However, supplier price increases and wage and benefit inflation, both of which represent a significant component of our costs of operations, may have a material effect on our operations and financial position in 2019 and beyond if we are unable to pass through any applicable increases under our present contracts or through to our markets in general.

Liquidity and Capital Resources

Our cash and cash equivalents amounted to $1,015 on June 30, 2019, compared to $1,345 on December 31, 2018 and $1,341 on June 30, 2018. The net cash used in our operating activities was $1,940 for the six months ended June 30, 2019, compared to $603 for the same period in 2018. The net use of cash during both periods was driven primarily by a significant increase in accounts receivable at the end of the period. Net cash used in investing activities, specifically capital expenditures, was $389 during the six months ended June 30, 2019, compared to $132 for the six months ended June 30, 2018. Net cash provided by financing activities was $1,999 during the six months ended June 30, 2019, compared to $121 net cash provided for the same time period for 2018. We paid $107 for capital lease obligations during six months ended June 30, 2019 compared to $79 in the same period in 2018. On March 22, 2019 we entered a New Business Loan agreement with Libertyville for $500 which replaced the expiring prior year agreement. We paid the outstanding balance for the prior agreement of $300, on January 9, 2018 and had borrowings under our line of credit of $200 on March 30, 2018, which was subsequently repaid on April 4, 2018. Under the new agreement, we borrowed $500 on March 30, 2019, which was subsequently repaid on April 3, 2019. No additional borrowings were incurred at June 30, 2019. During the six months ending June 30, 2019, we drew 14 times from the Master Agreement totaling $5,846 with repayment of $5,432. The net borrowings for the six months ended June 30, 2019 was $414. On May 13, 2019, we sold approximately 4.2 million shares of our common stock to our largest investor for approximately $1,700 in proceeds. No selling commission or other remuneration was paid in connection with this transaction. We have used, and expect to continue to use, the proceeds for general corporate purposes.

Our supply agreements with our largest customer, BASF, contain certain financial covenants which could potentially impact our liquidity. The most restrictive financial covenants under these agreements require that we maintain a minimum of $1 million in total of certain assets of which at least $500 must be in cash, cash equivalents, and certain investments, with the balance being composed of certain inventory and receivables, and that we not have the acceleration of any debt maturity having a principal amount of more than $10 million, in order to avoid triggering the customer’s potential right to transfer certain technology and equipment to that customer at a contractually-defined price. We had approximately $1,015 in cash on June 30, 2019. During March 2019, we entered into a new line of credit, which expires in April 2020. This supply agreement and its covenants are more fully described in Note 12, and our line of credit is more fully described in Note 8, to our Financial Statements in Part I, Item 1 of this Form 10-Q.

We believe that cash from operations, proceeds from our recent equity financing, and cash on hand, in addition to unused borrowing capacity will be adequate to fund our operating plans through 2019. Given our expected growth in our Solésence^® business, we are monitoring the temporary working capital demands that this could create, with timing being the most critical variable. Our actual future capital requirements in 2019 and beyond will depend on many factors, including customer acceptance of our current and potential advanced materials, applications and product, continued progress in research and development activities and product testing programs, the magnitude of these activities and programs, and the costs necessary to increase and expand our manufacturing capabilities and to market and sell our advanced materials, applications and products. Other important issues that will drive future capital requirements will be the development of new markets and new customers as well as the potential for significant unplanned growth with existing customers. Depending on the success of certain projects, we expect that capital spending relating to currently known capital needs for the remainder of 2019 will be between $150 and $200, and we could enter into one or more financing leases to finance these acquisitions, subject to the provisions of our new Line of Credit Agreement with Libertyville and our Master Agreement relating to our business loans with Beachcorp, LLC. If those projects are delayed or ultimately prove unsuccessful, or if we fail to obtain financing on terms acceptable to us, we would expect our capital spending to be below the lower end of that range. Similarly, substantial success in business development projects may cause the actual capital investment for the remainder of 2019 to exceed the top of this range.

Should events arise that make it appropriate for us to seek additional financing, such additional financing may not be available on acceptable terms or even at all, and any such additional financing could be dilutive to our stockholders. Such financing could be necessitated by such things as the loss of one or more existing customers; a significant decrease in revenue from one or more of our customers; temporary working capital demands resulting from our expected growth in our Solésence^® business that we cannot fund with existing capital; currently unknown capital requirements in light of the factors described above; new regulatory requirements that are outside our control; the need to meet previously discussed cash requirements to avoid a triggering event under our BASF agreement, or various other circumstances coming to pass that we currently do not anticipate. The failure to have access to sufficient capital to fund our business plans may result in a curtailment or other change in those plans, and under such circumstances, may raise doubt as to our ability to continue as a going concern.

On June 30, 2019, we had a net operating loss carryforward of approximately $79 million for income tax purposes. Because we may have experienced “ownership changes” within the meaning of the U.S. Internal Revenue Code in connection with our various prior equity offerings, future utilization of this carryforward may be subject to certain limitations as defined by the Internal Revenue Code. If not utilized, the carryforward will expire at various dates between January 1, 2019 and December 31, 2036. Under recent changes in the Internal Revenue Code, losses incurred after January 1, 2018 carry forward indefinitely. As a result of the annual limitation and uncertainty as to the amount of future taxable income that will be earned prior to the expiration of the carryforward, we have concluded that it is likely that a substantial portion of this carryforward will expire before ultimately becoming available to reduce income tax liabilities. Changes in Illinois state law that began in 2011 will impact net loss carryforward duration and utilization on the state tax level.

Off−Balance Sheet Arrangements

We have not created, and are not party to, any special-purpose or off-balance sheet entities for the purposes of raising capital, incurring debt or operating our business. We do not have any off-balance sheet arrangements or relationships with entities that are not consolidated into our financial statements that are reasonably likely to materially affect our liquidity or the availability of capital resources.

As more fully described in Note 8 to our Financial Statements, in Part I, Item I of this Form 10-Q, during 2014 we entered into a letter of credit and promissory note for up to $30 supporting our obligations under our facility lease agreement. No borrowings have been incurred under this promissory note.

Safe Harbor Provision

We want to provide investors with more meaningful and useful information. As a result, this Quarterly Report on Form 10-Q (the “Form 10-Q”) contains and incorporates by reference certain “forward-looking statements”, as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements reflect our current expectations of the future results of our operations, performance and achievements. Forward-looking statements are covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We have tried, wherever possible, to identify these statements by using words such as “anticipates”, “believes”, “estimates”, “expects”, “plans”, “intends” and similar expressions. These statements reflect management’s current beliefs and are based on information now available to it. Accordingly, these statements are subject to certain risks, uncertainties and contingencies that could cause our actual results, performance or achievements in 2019 and beyond to differ materially from those expressed in, or implied by, such statements. These risks, uncertainties and factors include, without limitation: our ability to be consistently profitable despite the losses we have incurred since our incorporation; a decision by a customer to cancel a purchase order or supply agreement in light of our dependence on a limited number of key customers; the terms of our supply agreements with BASF, which could trigger a requirement to transfer technology and/or sell equipment to that customer; our potential inability to obtain working capital when needed on acceptable terms or at all; our ability to obtain materials at costs we can pass through to our customers, including Rare Earth elements, specifically cerium oxide, as well as high purity zinc; uncertain demand for, and acceptance of, our nanocrystalline materials and Solésence® products; our manufacturing capacity and product mix flexibility in light of customer demand; our limited marketing experience, including with our suite of Solésence® products; changes in development and distribution relationships; the impact of competitive products and technologies; our dependence on patents and protection of proprietary information; the resolution of litigation or other legal proceedings in which we may become involved; our ability to maintain an appropriate electronic trading venue for our securities; and the impact of any potential new governmental regulations that could be difficult to respond to or costly to comply with. In addition, our forward-looking statements could be affected by general industry and market conditions and growth rates. Readers of this Quarterly Report on Form 10-Q should not place undue reliance on any forward-looking statements. Except as required by federal securities laws, we undertake no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Not required for a smaller reporting company.

Item 4.

Controls and Procedures

Disclosure controls

We are responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed by us in the reports filed by us under the Exchange Act is: (a) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (b) accumulated and communicated to our management, including our principal executive and principal financial officers, to allow timely decisions regarding required disclosures. It should be noted that in designing and evaluating our disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that our management necessarily was required to apply its judgment regarding the design of our disclosure controls and procedures. As of the end of the period covered by this report, we conducted an evaluation, under the supervision (and with the participation) of our management, including our Chief Executive Officer (principal executive officer, and principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures were effective at reaching that level of reasonable assurance.

Internal control over financial reporting

The Company’s management, including the CEO (who is also currently acting as both the Company’s principal executive officer and the Company’s principal financial officer), confirm that there was no change in the Company’s internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings

We are not a party to any pending legal proceedings or claims that we believe will result in a material adverse effect on our business, financial condition, or operating results.

Item 1A.

Risk Factors

In addition to the information set forth in this Quarterly Report on Form 10-Q and before deciding to invest in, or retain, shares of our common stock, you also should carefully review and consider the information contained in our other reports and periodic filings that we make with the Securities and Exchange Commission, including, without limitation, the information contained under the caption Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018. Those risk factors could materially affect our business, financial condition and results of operations. Additional risks and uncertainties that we do not currently know about, we currently believe are immaterial or we have not predicted may also harm our business operations or adversely affect us. If any of these risks or uncertainties actually occurs, our business, financial condition, results of operations, cash flows or stock price could be materially adversely affected.

In addition to the risk factors previously disclosed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2018, investors should consider the following risk factors:

Our Ability to Continue as a Going Concern is in Doubt Absent Obtaining Adequate New Financing

We incurred a net loss of approximately $1.2 million in the first half of 2019, approximately $2.1 million in fiscal year 2018 and $0.8 million in fiscal year 2017. We anticipate that we will continue to lose money for the foreseeable future. We believe that cash from operations, cash on hand, cash from our May 13, 2019 financing, in addition to unused borrowing capacity, should be adequate to fund our operating plans through 2019, but this is dependent on several things over which we have limited control. Our largest customer made up 74% of our 2018 revenue and we expect a material reduction in orders from them in 2019, which has limited our flexibility and required us to make cash management a top priority. We also expect growth in our Solésence® business, which we view as a critical strategic undertaking, and may require additional investment in working capital. Our current plan is to continue to invest in Solésence®-related operating expenses and capital equipment. Given the uncertainties relating to our largest customer, as well as our growth strategy for Solésence®, it is possible that we may need to seek additional funding to address working capital demands within the next twelve months. We believe that we will be able to secure additional financing if needed, but we do not have any additional financing commitments in place as of today. However, we may not be able to secure additional financing in a timely manner under commercially reasonable terms, or at all. If we are unable to secure additional financing, we would need to delay capital expenditures related to our Solésence® growth strategy, which could impede growth in 2019 and 2020.

These circumstances raise significant doubt as to the Company’s ability to operate as a going concern for the next 12 months, and inability to fund our ongoing cash obligations may result in our ceasing to operate, which would result in liquidation of our assets. In a liquidation of the Company, if we are unable to continue as a going concern, the value realized on our assets would likely be less than our outstanding obligations and, consequently, our stockholders would lose their entire investment.

A Majority of our Common Stock is Controlled by a Single Stockholder

Together with his affiliates Grace Brothers, Ltd. and Grace Investments, Ltd., Bradford T. Whitmore beneficially owned 53% of our common stock as of May 13, 2019. Therefore, Mr. Whitmore has the legal power, regardless of the votes of our other stockholders, to elect all the members of the Company’s board of directors. Consequently, our board of directors and management may be strongly influenced by our controlling stockholder, and the interests of our current controlling stockholder may conflict with the interests of other stockholders.

Pursuant to the General Corporation Law of the State of Delaware and our Bylaws, our controlling stockholder is empowered to elect the majority of our board of directors, exercise overall control over our management, determine our policies, sell or, in any other manner, transfer shares representing control over the Company held by him and determine the result of any deliberation of our stockholders, including transactions with related parties, corporate reorganizations, sale of all or substantially all the assets, or delisting our shares from the OTCQB marketplace, as well as to determine the distribution and payment of any future dividends. Our controlling stockholder may have an interest in acquisitions, disposal of assets and partnerships, may seek funding or may take other decisions that could conflict with the interests of other stockholders and which may not result in any improvement in our operating results.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

On May 13, 2019, we sold 4,189,000 shares of our common stock, $0.01 par value per share (“Common Stock”) to Bradford T. Whitmore for an aggregate purchase price of $1,675,600 representing a price of $0.40 per share of Common Stock. Together with his affiliates Grace Brothers, Ltd. and Grace Investments, Ltd., Mr. Whitmore beneficially owned approximately 47% of the outstanding shares of our common stock as of March 25, 2019 and owned approximately 53% of our common stock as of May 13, 2019. Through his affiliate Beachcorp, LLC, Mr. Whitmore is also a substantial lender to the Company under the Business Loan Agreement, dated November 16, 2018 (see Note 8 to our financial statements in Part I of this Quarterly Report on Form 10-Q). The Company did not engage an underwriter for this transaction, and no selling commission or other remuneration was paid in connection with this transaction. We have used, and expect to continue to use, the proceeds for general corporate purposes. The sale of Common Stock to Mr. Whitmore was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) of Regulation D promulgated under the Securities Act because Mr. Whitmore has a preexisting relationship with the Company as its largest stockholder, Mr. Whitmore represented to the Company that he has assets or income sufficient to qualify as an accredited investor, as defined under Regulation D, and the Company did not engage in any general solicitation or general advertising in offering such securities.

In connection with the sale of Common Stock, the Company entered into a Common Stock Purchase Agreement, dated May 13, 2019, with Mr. Whitmore, providing for the unregistered sale to Mr. Whitmore of the number shares of Common Stock stated above for the consideration stated above and otherwise including representations, warranties and registration rights which are customary for similar private placements. The complete text of the Common Stock Purchase Agreement, dated May 13, 2019, between the Company and Mr. Whitmore was filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2019, which was filed with the SEC on May 15, 2019, and this summary is qualified in its entirety by reference to such Exhibit 4.1.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

Item 6.

Exhibits

	Exhibit 4.1	Common Stock Purchase Agreement, dated May 13, 2019, between the Company and Bradford T. Whitmore (incorporated by reference to Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2019, which was filed with the SEC on May 15, 2019).

	Exhibit 10.1	Joint Development Agreement, dated July 31, 2019, between the Company and Sumitomo Corporation of Americas (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K which was filed with the SEC on August 2, 2019).

	Exhibit 31.1	Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.

	Exhibit 31.2	Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.

	Exhibit 32	Certification of the Chief Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

	Exhibit 101	The following materials from Nanophase Technologies Corporation’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, formatted in XBRL (Extensible Business Reporting Language): (1) the Balance Sheets, (2) the Statements of Operations, (3) the Statements of Stockholders Equity, (4) the Statements of Cash Flows, and (5) the Notes to Unaudited Consolidated Condensed Financial Statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NANOPHASE TECHNOLOGIES CORPORATION

Date: August 14, 2019		By:	/s/ JESS A. JANKOWSKI
				Jess A. Jankowski
				President and Chief Executive Officer
				(principal executive officer, and principal financial officer)

EX-31.1 2 ex31-1.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Nanophase Technologies Corporation 10-Q

Exhibit 31.1

Certification of the Chief Executive Officer

Pursuant to

Rules 13a-14(a) and 15d-14(a) under the Exchange Act

I, Jess A. Jankowski, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Nanophase Technologies Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2019

	/s/ JESS A. JANKOWSKI
	Jess A. Jankowski
	(principal executive officer, and principal financial officer)

EX-31.2 3 ex31-2.htm CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

Nanophase Technologies Corporation 10-Q

Exhibit 31.2

Certification of the Principal Financial Officer

Pursuant to

Rules 13a-14(a) and 15d-14(a) under the Exchange Act

I, Jess Jankowski, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Nanophase Technologies Corporation;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2019

	/s/ JESS A. JANKOWSKI
	Jess A. Jankowski
	(principal executive officer, and principal financial officer)

EX-32 4 ex32.htm CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

Nanophase Technologies Corporation 10-Q

Exhibit 32

Certification Pursuant to 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with this quarterly report of Nanophase Technologies Corporation (the “Company”) on Form 10-Q for the quarter ending June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jess A. Jankowski, Chief Executive Officer, and acting as Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to our knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: August 14, 2019

	/s/ JESS A. JANKOWSKI
	Jess A. Jankowski
	Chief Executive Officer
	(principal executive officer, and principal financial officer)

EX-101.INS 5 nanx-20190630.xml XBRL INSTANCE DOCUMENT 0000883107 2019-01-01 2019-06-30 0000883107 2019-08-14 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-06-30 0000883107 2018-01-01 2018-06-30 0000883107 2019-04-01 2019-06-30 0000883107 2018-04-01 2018-06-30 0000883107 us-gaap:LineOfCreditMember nanx:NewBusinessLoanAgreementMember 2019-03-21 2019-03-22 0000883107 nanx:BusinessLoanAgreementMember nanx:BeachcorpLLCMember 2018-11-15 2018-11-16 0000883107 nanx:BusinessLoanAgreementMember us-gaap:RevolvingCreditFacilityMember nanx:BeachcorpLLCMember 2018-11-15 2018-11-16 0000883107 2019-03-31 0000883107 us-gaap:LineOfCreditMember nanx:NewBusinessLoanAgreementMember 2019-03-22 0000883107 us-gaap:LineOfCreditMember nanx:NewBusinessLoanAgreementMember 2018-12-31 0000883107 2018-12-31 0000883107 nanx:BusinessLoanAgreementMember nanx:BeachcorpLLCMember 2018-11-16 0000883107 nanx:BusinessLoanAgreementMember us-gaap:RevolvingCreditFacilityMember nanx:BeachcorpLLCMember 2018-11-16 0000883107 us-gaap:LineOfCreditMember nanx:BusinessLoanAgreementMember us-gaap:IndividuallyImmaterialCounterpartiesMember 2019-06-30 0000883107 us-gaap:LineOfCreditMember nanx:NewBusinessLoanAgreementMember 2019-06-30 0000883107 nanx:BusinessLoanAgreementMember nanx:BeachcorpLLCMember 2018-01-01 2018-06-30 0000883107 nanx:BusinessLoanAgreementMember nanx:BeachcorpLLCMember 2019-01-01 2019-06-30 0000883107 nanx:BusinessLoanAgreementMember nanx:BeachcorpLLCMember 2019-04-01 2019-06-30 0000883107 nanx:BusinessLoanAgreementMember nanx:BeachcorpLLCMember 2018-04-01 2018-06-30 0000883107 nanx:BeachcorpLLCMember 2019-01-01 2019-06-30 0000883107 nanx:BusinessLoanAgreementMember nanx:BeachcorpLLCMember 2019-06-30 0000883107 2019-06-30 0000883107 us-gaap:NewAccountingPronouncementMember 2019-01-02 0000883107 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0000883107 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0000883107 2019-01-01 2019-03-31 0000883107 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0000883107 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0000883107 us-gaap:EmployeeStockOptionMember 2019-06-30 0000883107 us-gaap:EmployeeStockOptionMember 2018-12-31 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersThreeMember 2019-01-01 2019-06-30 0000883107 us-gaap:SupplyCommitmentMember srt:MaximumMember 2019-01-01 2019-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersOneMember 2019-01-01 2019-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersTwoMember 2019-01-01 2019-06-30 0000883107 us-gaap:SupplyCommitmentMember srt:MinimumMember 2019-09-30 0000883107 nanx:CustomersThreeMember 2019-06-30 0000883107 nanx:CustomersOneMember 2019-06-30 0000883107 nanx:CustomersTwoMember 2019-06-30 0000883107 us-gaap:SupplyCommitmentMember srt:MinimumMember 2019-06-30 0000883107 nanx:CustomersOneMember 2018-06-30 0000883107 nanx:CustomersThreeMember 2018-06-30 0000883107 nanx:CustomersTwoMember 2018-06-30 0000883107 us-gaap:ManufacturedProductOtherMember 2019-01-01 2019-06-30 0000883107 nanx:AdvancedMaterialsMember 2019-01-01 2019-06-30 0000883107 nanx:SolesenceMember 2019-01-01 2019-06-30 0000883107 us-gaap:ManufacturedProductOtherMember 2018-01-01 2018-06-30 0000883107 nanx:AdvancedMaterialsMember 2018-01-01 2018-06-30 0000883107 nanx:SolesenceMember 2018-01-01 2018-06-30 0000883107 us-gaap:ManufacturedProductOtherMember 2019-04-01 2019-06-30 0000883107 us-gaap:ManufacturedProductOtherMember 2018-04-01 2018-06-30 0000883107 nanx:AdvancedMaterialsMember 2019-04-01 2019-06-30 0000883107 nanx:AdvancedMaterialsMember 2018-04-01 2018-06-30 0000883107 nanx:SolesenceMember 2019-04-01 2019-06-30 0000883107 nanx:SolesenceMember 2018-04-01 2018-06-30 0000883107 us-gaap:NonUsMember 2019-01-01 2019-06-30 0000883107 us-gaap:NonUsMember 2018-01-01 2018-06-30 0000883107 us-gaap:NonUsMember 2019-04-01 2019-06-30 0000883107 us-gaap:NonUsMember 2018-04-01 2018-06-30 0000883107 2018-03-31 0000883107 2017-12-31 0000883107 us-gaap:ProductMember 2019-01-01 2019-06-30 0000883107 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-06-30 0000883107 us-gaap:ProductMember 2018-01-01 2018-06-30 0000883107 us-gaap:ProductAndServiceOtherMember 2018-01-01 2018-06-30 0000883107 us-gaap:ProductMember 2019-04-01 2019-06-30 0000883107 us-gaap:ProductAndServiceOtherMember 2019-04-01 2019-06-30 0000883107 us-gaap:ProductMember 2018-04-01 2018-06-30 0000883107 us-gaap:ProductAndServiceOtherMember 2018-04-01 2018-06-30 0000883107 2018-01-01 2018-03-31 0000883107 2018-06-30 0000883107 us-gaap:SubsequentEventMember nanx:JointDevelopmentAgreementMember nanx:SumitomoCorporationOfAmericasMember 2019-07-01 2019-07-31 0000883107 us-gaap:SubsequentEventMember nanx:JointDevelopmentAgreementMember nanx:SumitomoCorporationOfAmericasMember 2019-07-31 0000883107 us-gaap:CommonStockMember 2017-12-31 0000883107 us-gaap:CommonStockMember 2018-03-31 0000883107 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000883107 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000883107 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000883107 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000883107 us-gaap:RetainedEarningsMember 2017-12-31 0000883107 us-gaap:RetainedEarningsMember 2018-03-31 0000883107 us-gaap:CommonStockMember 2018-06-30 0000883107 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000883107 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000883107 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0000883107 us-gaap:RetainedEarningsMember 2018-06-30 0000883107 us-gaap:CommonStockMember 2018-12-31 0000883107 us-gaap:CommonStockMember 2019-03-31 0000883107 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000883107 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000883107 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000883107 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000883107 us-gaap:RetainedEarningsMember 2018-12-31 0000883107 us-gaap:RetainedEarningsMember 2019-03-31 0000883107 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000883107 us-gaap:CommonStockMember 2019-06-30 0000883107 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000883107 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000883107 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000883107 us-gaap:RetainedEarningsMember 2019-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersOneMember 2019-04-01 2019-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersTwoMember 2019-04-01 2019-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersThreeMember 2019-04-01 2019-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersOneMember 2018-01-01 2018-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersTwoMember 2018-01-01 2018-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersThreeMember 2018-01-01 2018-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersOneMember 2018-04-01 2018-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersTwoMember 2018-04-01 2018-06-30 0000883107 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember nanx:CustomersThreeMember 2018-04-01 2018-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares nanx:Number xbrli:pure NANOPHASE TECHNOLOGIES Corp 0000883107 10-Q false 2019-06-30 000-22333 DE --12-31 Yes Yes true Non-accelerated Filer false false 38136792 Q2 2019

0.74

0.03

0.59

0.12

0.65

0.05

0.04

0.73

0.06

0.03

0.66

0.10

0.04

0.00

671000

681000

409000

1062000

0.01

0.03

Prime rate

500000

2000

345000

0.75 2

500000

2020-04-04

2020-03-31

86000

300000

500000

0.0825

2020-12-31

The Term Loan and Revolver Facility are secured by all the unencumbered assets of the Company and subordinated to Libertyville’s secured interest under the New Business Loan Agreement.

0.53

832000

1246000

20000

93000

50000

9000

59000

7000

1086000

1118000

2329000

2159000

87000

66000

2242000

2093000

64000 31000

30000

14000

34000

17000

416000

211000

352000

180000

52000

30000

54000

27000

246000

123000

336000

0.091

0.144

P2Y4M24D

P3Y6M

617000

85000

702000

5000

109000

196000

255000

137000

1059000

3426000

580000

642000

632000

618000

616000

338000

2984000 1144000 4128000 580000 647000 741000 814000 871000 475000

2059000

2212000

329000

2038000

2367000

2556000

0.025

0.029

0.025

0.029

0.0000

P7Y

0.94

0.64

0.67

0.66

115000

88000

58000

43000

486000

P2Y

547500

570500

130500

188504

3747400

3415000

0.64

0.67

36000

7049000

7014000

3294000

4116000

4160000

1600000

1289000

5228000

1274000

512000

2151000

2923000

750000

742000

393000

451000

6754000

295000

6910000

104000

3257000

37000

4043000

73000

700000

183000

243000

164000

1345000

1015000

1955000

1341000

829000

1652000

93000

843000

212000

927000

76000

54000

273000

351000

4689000

5111000

1865000

2127000

15000

14000

6569000

9311000

218000

227000

1608000

1423000

979000

925000

3637000

4150000

506000

390000

500000

344000

198000

202000

1548000

3130000

339000

381000

98795000

100560000

-97750000

-98910000

928000

1384000

2031000

2351000

3232000

2484000

338000

98563000

98606000

-95669000

-96593000

338000

98651000

-96505000

339000

98795000

98852000

-97750000

-98263000

381000

100560000

-98910000

6569000

9311000

9000

0.01

24088

0.01

42000000

33911792

38100792

33911792

38100792

1716000

1815000

832000

1405000

5333000

5199000

2462000

2711000

-1160000

-836000

-647000

88000

-513000

-924000

88000

-513000

-647000

-1160000

-836000

-647000

88000

93000

20000

50000

9000

-1067000

-816000

-597000

97000

1821000

1535000

944000

770000

962000

1096000

485000

538000

35030422

33847793

36136759

34909793

-0.03

-0.02

35030422

33847793

36136759

33847793

-0.03

-0.02

115000

88000

16000

155000

166000

-1940000

-603000

36000

-54000

102000

-224000

563000

78000

109000

-149000

264000

823000

313000

-389000

-132000

389000

132000

-330000

-614000

1999000

121000

16000

1676000

5432000

5846000

500000

700000

107000

79000

86000

20000

45000

39000

8000

1243000

1041000

500000

250000

P10Y

33847793

33911792

38136792

58000

45000

57000

43000

45000

57000

58000

16000

1676000

42000

1634000

4189000

3 0

500000

1000000

10000000

(1) Basis of Presentation    The accompanying unaudited consolidated condensed interim financial statements of Nanophase Technologies Corporation (“Nanophase”, “Company”, “we”, “our”, or “us”) reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management, are necessary for a fair presentation of our financial position and operating results for the interim periods presented. All statements include the results from both Nanophase and our wholly-owned subsidiary, Solesence, LLC (“Solésence,” or our “Solésence® subsidiary”). Operating results for the three and six months ended June 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019.   These financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December 31, 2018, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the Securities and Exchange Commission.

(2) Going Concern / Liquidity   We believe that cash from operations, cash on hand, cash from our May 13, 2019 financing, in addition to unused borrowing capacity, should be adequate to fund our operating plans through 2019, but this is dependent on several things over which we have limited control. Our largest customer made up 74% of our 2018 revenue and we expect a material reduction in orders from them in 2019, which has limited our flexibility and required us to make cash management a top priority. We also expect growth in our Solésence® business, which we view as a critical strategic undertaking, and may require additional investment in working capital. Our current plan is to continue to invest in Solésence®-related operating expenses and capital equipment. Given the uncertainties relating to our largest customer, as well as our growth strategy for Solésence®, it is possible that we may need to seek additional funding to address working capital demands within the next twelve months. We believe that we will be able to secure additional financing if needed, but we do not have any additional financing commitments in place as of today. However, we may not be able to secure additional financing in a timely manner under commercially reasonable terms, or at all. If we are unable to secure additional financing, we would need to delay capital expenditures related to our Solésence® growth strategy, which could impede growth in 2019 and 2020.    These circumstances raise significant doubt as to the Company’s ability to operate as a going concern under U.S. GAAP. The accompanying financial statements have been prepared on a going concern basis in accordance with U.S. GAAP. As such, no adjustments have been made to the unaudited condensed consolidated financial statements for the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue operating as a going concern.

(3) Summary of Significant Accounting Policies    Recently Adopted Financial Accounting Standards    On January 1, 2019, the Company adopted Accounting Standards Update (“ASU”) No. 2016-02, Leases, ASU No. 2018-10, Codification Improvements to Topic 842 (Leases) and ASU No. 2018-11, Targeted Improvements to Topic 842 (Leases). The guidance is intended to increase transparency and comparability among companies for leasing transactions, including a requirement for companies that lease assets to recognize on their balance sheets the assets and liabilities for the rights and obligations created by those leases. The guidance also provides for disclosures that allow the users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.   The Company adopted the guidance on January 1, 2019 using the modified retrospective method without restatement of comparative periods. As such, periods prior to the date of adoption are presented in accordance with ASC 840 - Leases. The Company utilized the available practical expedient that allowed for the Company to not reassess whether existing contracts contain a lease under the new definition of a lease, lease classification for existing leases and whether previously capitalized initial direct costs would qualify for capitalization under the new guidance.   The adoption of this guidance had a material impact on the Consolidated Condensed Balance Sheet as of June 30, 2019 due to the recognition of equal right-of-use assets and lease liabilities for the Company’s portfolio of operating leases. The right-of-use asset balance was then adjusted by the reclassification of pre-existing accrued rent balances from other line items within the Consolidated Condensed Balance Sheet. The adoption had an immaterial impact to the Consolidated Condensed Statement of Cash Flows and to the Consolidated Condensed Statement of Operations for the three and six months ended June 30, 2019. The adoption had no impact to the Consolidated Condensed Statement of Changes in Stockholders’ Equity for the three and six months ended June 30, 2019. Additional information and disclosures required by the new standard are contained in Note 10, Leases.

(4) Description of Business   Nanophase is a skin and sun care focused company that offers engineered materials, formulation development and commercial manufacturing with an integrated family of technologies. We look at our products in three major product categories; Personal Care Ingredients, including sunscreens as active ingredients; Solésence, including full formulations of skin care products, marketed and sold by our wholly-owned subsidiary, Solesence, LLC (“Solésence,” or our “Solésence® subsidiary”); and Advanced Materials, including architectural and industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, and a variety of surface finishing technologies (polishing).   We target markets in which we believe practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers, and our Solésence® products to cosmetics and skin care brands. Recently developed technologies have made certain new products possible and opened potential new markets. During 2015 we were granted a patent on a new type of particle surface treatment (coating) — now called Active Stress Defense™ Technology — which became the cornerstone of our new product development in personal care, with first revenue recognized during 2016. In addition, through the creation of our Solésence® subsidiary, we utilize this particle surface treatment to manufacture and sell fully developed solutions to targeted customers in the skin care industry, in addition to the ingredients we have traditionally sold in the personal care area.   Although our primary strategic focus has been the North American market, we currently sell material to customers overseas and have been working to expand our reach within foreign markets. The Company was incorporated in Illinois on November 25, 1989 and became a Delaware corporation during November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.   While product sales comprise the majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected to drive the long-term growth of the business. For this reason, we classify such revenue as “other revenue” in our Consolidated Condensed Statements of Operations, as it does not represent revenue directly from the sale of our products.

(5) Revenues   Revenues are recognized at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods.   Customers deposits, deferred revenue and other receipts are deferred and recognized when the revenue is realized and earned. Cash payments to customers are classified as reductions of revenue in the Company’s Consolidated Condensed Statement of Operations.

(6) Earnings Per Share   Earnings (Loss) Per Share is computed using the Treasury Stock Method. Options to purchase approximately 409,000 shares of common stock that were outstanding for the three months ended June 30, 2019, which were not included in the computation of diluted earnings (loss) per share as the impact of such shares would be anti-dilutive. For the three months ended June 30, 2018, options to purchase approximately 1,062,000 shares of common stock were outstanding and were included in the computation of diluted earnings (loss) per share for the three months ended June 30. This had a $0.00 impact per diluted share for the three months ended June 30, 2018. Options to purchase approximately 671,000 and 681,000 shares of common stock that were outstanding as of June 30, 2019 and June 30, 2018, respectively, were not included in the computation of diluted earnings (loss) per share for the six months ended June 30, 2019 and June 30, 2018, as the impact of such shares would be anti-dilutive.

(7) Financial Instruments    We follow the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.   Our financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with the promissory note with no related borrowings described in Note 8, and any borrowings on the working capital line of credit from Libertyville Bank and Trust and any borrowings under the Master Agreement from Beachcorp, LLC described below in Note 8. The fair values of all financial instruments were not materially different from their carrying values. There were no financial assets or liabilities adjusted to fair value on June 30, 2019 or December 31, 2018.

(8) Notes and Line of Credit   During July 2014 we entered into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our obligations under our facility lease agreement. No borrowings have been incurred under this promissory note. Should any borrowings occur in the future, the interest rate would be the prime rate plus 1%, with the bank having the right to “set off” or apply unpaid balances against our checking account if we fail to meet our obligations under any borrowings under the note. It is our intention to renew this note annually, for as long as we need to do so pursuant to the terms of our facility lease agreement. This note was renewed through July 1, 2020. Because there were no amounts outstanding on the note at any time during 2019 or 2018, we have recorded no related liability on our balance sheet.   On March 22, 2019, we executed a New Business Loan Agreement, dated as of March 4, 2019, with Libertyville Bank and Trust Company, a Wintrust Community Bank (“Libertyville”), our primary bank, which replaces the Line of Credit Agreement with Libertyville having a maturity date of March 4, 2019. Under the New Business Loan Agreement, Libertyville will provide a maximum of (i) $500 or (ii) two times the sum of (a) 75% our eligible accounts receivables and (b) our cash deposited with Libertyville, whichever is less, of revolving credit to us, collateralized by a senior priority lien on our accounts receivable, inventory, equipment, general intangibles and fixtures. Interest is payable monthly on any advances at a floating interest rate of the prime rate at the time plus 1%. We must have $500 in cash, inclusive of the borrowed amount, at Libertyville on the date of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be repaid in full within five business days of the advance. Amounts due under the Line of Credit Agreement must be paid in full on April 4, 2020. There was no outstanding balance on this loan at June 30, 2019 or December 31, 2018.   On November 16, 2018, we entered into a Business Loan Agreement (the “Master Agreement”) with Beachcorp, LLC. Beachcorp, LLC is managed by Bradford T. Whitmore, who, together with his affiliates Grace Brothers, Ltd. and Grace Investments, Ltd., beneficially owned approximately 53% of our common stock as of May 13, 2019, pursuant to our 2019 financing. The Master Agreement relates to two loan facilities, each evidenced by separate promissory notes, each dated November 16, 2018: a term loan to the Company of up to $500 to be disbursed in a single advance (the “Term Loan”) with a fixed annual interest rate of 8.25%, payable quarterly, accruing from the date of such advance and with principal due on December 31, 2020; and an asset-based revolving loan facility for the Company of up to $2,000 (the “Revolver Facility”), with floating interest accruing at the prime rate plus 3% (8.25% minimum) per year, with a borrowing base consisting of qualified accounts receivable of the Company, and with all principal and accrued interest due March 31, 2020. The Term Loan and Revolver Facility are secured by all the unencumbered assets of the Company and subordinated to Libertyville’s secured interest under the New Business Loan Agreement. The Master Agreement substantially restricts the Company’s ability to incur additional indebtedness during the terms of both the Term Loan and the Revolver Facility. On June 30, 2019, the balance on the term loan was $500 and the balance on the Revolver Facility was $1,246. For the three months and six months ended June 30, 2019, interest expense was $50 and $93, respectively, compared to the same periods in 2018 of $9 and $20, respectively. For the six months ended June 30, 2019, $7 was accrued and $86 paid. As Beachcorp, LLC is an affiliate of one of our shareholders, $59 is interest to be paid to a related party. On June 30, 2019 borrowings were within the credit agreement limit with an additional $345 available. The balance of borrowing base, loan amount, and any excess payments required over the available borrowing base will change as frequently as daily, given the operational nature of the elements of the Revolver Facility.

(9) Inventories   Inventories consist of the following:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">June 30, 2019</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-weight: bold">December 31, 2018</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Raw materials</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 13%; text-align: right">1,118</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 13%; text-align: right">1,086</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">Finished goods</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">1,041</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">1,243</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,159</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,329</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">Allowance for excess inventory quantities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(66</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(87</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,093</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,242</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>

(10) Leases   The Company’s operating lease portfolio is comprised of operating leases for office, warehouse space and equipment. Certain of the Company’s leases include one or more options to renew or terminate the lease at the Company’s discretion. The Company regularly evaluates the renewal and termination options and when they are reasonably certain of exercise, includes the renewal or termination option in our lease term.   The adoption of Topic 842 resulted in the Company recognizing operating lease liabilities totaling $2,556 with a corresponding right-of-use (“ROU”) asset of $2,212 based on the present value of the minimum rental payments of such leases. The variance between the ROU asset balance and the lease liability is deferred rent liability that existed prior to the adoption of the ASC 842 and was offset against the ROU asset balance during the adoption. As of June 30, 2019, the ROU asset had a balance of $2,059 which is included in the “Operating lease right-of-use assets” line item of these condensed consolidated financial statements and current and non-current lease liabilities related to the ROU asset of $329 and $2,038 respectively, and are included in the “Current portion of operating lease obligations” and “Long-term portion of operating lease obligations” line items of these condensed consolidated financial statements. The discount rates used for leases accounted for under ASC 842 are based on an interest rate yield curve developed for the leases in the Company’s portfolio.   The office leases contain variable lease payments which consist primarily of rent escalations based on an established index or rate and taxes, insurance, and common area or other maintenance costs, which are paid based on actual costs incurred by the lessor. The Company has elected to utilize the available practical expedient to not separate lease and non-lease components.   Quantitative information regarding the Company’s leases is as follows:    <table cellspacing="0" cellpadding="0" style="width: 95%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Three Months Ended June 30, 2019</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Six Months Ended June 30, 2019</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Components of lease cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Finance lease cost components:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Amortization of finance lease assets</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">17</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">34</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Interest on finance lease liabilities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">14</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">30</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.375in; text-indent: -8.65pt">Total finance lease costs</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">31</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">64</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Operating lease cost components:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Operating lease cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">123</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">246</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Variable lease cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">27</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">54</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Short-term lease cost</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">30</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">52</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.375in; text-indent: -8.65pt">Total operating lease costs</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">180</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">352</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 8.65pt; text-indent: -8.65pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2pt; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Total lease cost</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">211</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">416</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>    Supplemental cash flow information related to leases is as follows for the six months ended June 30, 2019:    <table cellspacing="0" cellpadding="0" style="width: 95%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td>Cash paid for amounts included in the measurement of lease liabilities:</td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; text-align: left">Operating cash outflow from operating leases</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">336</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term-finance leases (in years)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2.4</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Weighted-average remaining lease term-operating leases (in years)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3.5</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average discount rate-finance leases</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">9.1</td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Weighted-average discount rate-operating leases</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">14.4</td> <td style="text-align: left">%</td></tr> </table>   The future maturities of the Company’s finance and operating leases as of June 30, 2019 is as follows:    <table cellspacing="0" cellpadding="0" style="width: 95%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Finance Leases</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Operating Leases</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Total</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">2019</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">137</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">338</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">475</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2020</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">255</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">616</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">871</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2021</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">196</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">618</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">814</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2022</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">109</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">632</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">741</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2023</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">642</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">647</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">2024 and thereafter</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">580</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">580</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total payments</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">702</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">3,426</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">4,128</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">Less amounts representing interest</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(85</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(1,059</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(1,144</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: left">Total minimum payments required:</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">617</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,367</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,984</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>

(12) Significant Customers and Contingencies    Revenue from three customers constituted approximately 65%, 5% and 4%, respectively, of our total revenue for the three months ended June 30, 2019. For the six months ended June 30, 2019, revenue from the same three customers was approximately 59%, 12% and 3%, respectively. Amounts included in accounts receivable on June 30, 2019 relating to these three customers were approximately $843, $212 and $93, respectively. Revenue from these three customers constituted approximately 66%, 10% and 4%, respectively, for the three months ended June 30, 2018. For the six months ended June 30, 2018, revenue from the same three customers was approximately 73%, 6% and 3%, respectively. Amounts included in accounts receivable on June 30, 2018 relating to these three customers were approximately $927, $54 and $76, respectively. The loss of one of these significant customers, a significant decrease in revenue from one or more of these customers, or the failure to attract new customers could have a material adverse effect on our business, results of operations and financial condition.   We currently have exclusive supply agreements with BASF Corporation (“BASF”), our largest customer, that have contingencies outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended to provide capacity sufficient to meet the customer’s production needs. This outcome may occur if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition covenants in one of our supply agreements with BASF “trigger” a technology transfer right (license and equipment sale at BASF’s option) in the event (a) that earnings for the twelve-month period ending with our most recently published quarterly financial statements are less than zero and a minimum of $1 million in total of certain assets of which at least $500 must be in cash, cash equivalents and certain investments, with the balance being composed of certain inventory and receivables, is not maintained or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. There are certain minimum finished goods inventory requirements with the 2019 amendment to the supply agreement. This agreement also requires Nanophase to maintain certain finished goods inventory levels as “safety stock,” beginning in the first quarter of 2019, and increasing through the third quarter of 2019 to a negotiated level based on agreed demand metrics, in order to maintain the $500 non-cash component discussed above. After September 30, 2019, should our safety stock fall below the prescribed amount of material, the quarter-end cash requirement would revert to $1,000 in cash, cash equivalents, and certain investments. The safety stock requirement may be adjusted upon mutual agreement.   Our supply agreements with BASF also “trigger” a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment’s net book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the equipment’s net book value, depending on the equipment and related products.   We believe that we should have sufficient cash and credit availability (See the description of our New Line of Credit Agreement with Libertyville and the Master Agreement with Beachcorp, LLC (described in Note 8) to operate our business during 2019, but this is dependent on several things over which we have limited control. If a triggering event were to occur and BASF elected to proceed with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities. We believe that our employees are a critical component of our success and it could be difficult to replace them quickly. Given the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.   We expect to expend resources on research, development and product testing, and in expanding current capacity or capability for new business. In addition, we may incur significant costs in preparing, filing, prosecuting, maintaining and enforcing our patents and other proprietary rights. We may need additional financing if we were to lose an existing customer or suffer a significant decrease in revenue from one or more of our customers or because of currently unknown capital requirements, new regulatory requirements or the need to meet the cash requirements discussed above to avoid a triggering event under our BASF agreement. Given our expected growth in our Solésence® business, we may also have temporary working capital demands that we cannot fund with existing capital, while remaining in compliance with the covenants included in our BASF agreement described above. If necessary, we may seek funding through public or private financing and through contracts with governmental entities or other companies. Additional financing may not be available on acceptable terms or at all, and any such additional financing could be dilutive to our shareholders. If we are unable to obtain adequate funds, we may be required to delay, scale-back or eliminate some of our manufacturing and marketing operations or we may need to obtain funds through arrangements on less favorable terms. Such circumstances could raise doubt as to our ability to continue as a going concern. If we obtain funding on unfavorable terms, we may be required to relinquish rights to some of our intellectual property.

(13) Business Segmentation and Geographical Distribution    Revenue from international sources approximated $243 and $700 for the three and six months ended June 30, 2019, respectively, compared to $164 and $183 for the three and six months ended June 30, 2018, respectively. All of this revenue was product revenue.   Our Operations comprise a single business segment and all our long-lived assets are located within the United States. We categorize our revenue stream into three main product categories, Personal Care Ingredients, Advanced Materials and Solésence®. The revenues for the three months and six months ended June 30, 2019 and 2018, by category, are as follows:   <table cellspacing="0" cellpadding="0" style="width: 80%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="text-align: center">For the three months ended </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="text-align: center">For the six months ended</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">June 30</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">June 30</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold">Product Category</td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2019</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2018</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2019</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2018</td> <td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Personal Care Ingredients</td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">2,151</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">2,923</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">4,160</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">5,228</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Advanced Materials</td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">750</td> <td style="text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">742</td> <td style="text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,600</td> <td style="text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,274</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Solésence®</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">393</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">451</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">1,289</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">512</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: left">Total Sales</td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">3,294</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">4,116</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">7,049</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">7,014</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Recently Adopted Financial Accounting Standards    On January 1, 2019, the Company adopted Accounting Standards Update (“ASU”) No. 2016-02, Leases, ASU No. 2018-10, Codification Improvements to Topic 842 (Leases) and ASU No. 2018-11, Targeted Improvements to Topic 842 (Leases). The guidance is intended to increase transparency and comparability among companies for leasing transactions, including a requirement for companies that lease assets to recognize on their balance sheets the assets and liabilities for the rights and obligations created by those leases. The guidance also provides for disclosures that allow the users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.   The Company adopted the guidance on January 1, 2019 using the modified retrospective method without restatement of comparative periods. As such, periods prior to the date of adoption are presented in accordance with ASC 840 - Leases. The Company utilized the available practical expedient that allowed for the Company to not reassess whether existing contracts contain a lease under the new definition of a lease, lease classification for existing leases and whether previously capitalized initial direct costs would qualify for capitalization under the new guidance.   The adoption of this guidance had a material impact on the Consolidated Condensed Balance Sheet as of June 30, 2019 due to the recognition of equal right-of-use assets and lease liabilities for the Company’s portfolio of operating leases. The right-of-use asset balance was then adjusted by the reclassification of pre-existing accrued rent balances from other line items within the Consolidated Condensed Balance Sheet. The adoption had an immaterial impact to the Consolidated Condensed Statement of Cash Flows and to the Consolidated Condensed Statement of Operations for the three and six months ended June 30, 2019. The adoption had no impact to the Consolidated Condensed Statement of Changes in Stockholders’ Equity for the three and six months ended June 30, 2019. Additional information and disclosures required by the new standard are contained in Note 10, Leases.

Inventories consist of the following:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">June 30, 2019</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center; font-weight: bold">December 31, 2018</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Raw materials</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,118</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,086</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">Finished goods</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">1,041</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">1,243</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,159</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,329</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">Allowance for excess inventory quantities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(66</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(87</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,093</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,242</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>

Quantitative information regarding the Company’s leases is as follows:    <table cellspacing="0" cellpadding="0" style="width: 95%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Three Months Ended June 30, 2019</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Six Months Ended June 30, 2019</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Components of lease cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Finance lease cost components:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Amortization of finance lease assets</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">17</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">34</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Interest on finance lease liabilities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">14</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">30</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.375in; text-indent: -8.65pt">Total finance lease costs</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">31</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">64</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Operating lease cost components:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Operating lease cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">123</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">246</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Variable lease cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">27</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">54</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.25in; text-indent: -8.65pt">Short-term lease cost</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">30</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">52</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.375in; text-indent: -8.65pt">Total operating lease costs</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">180</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">352</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 8.65pt; text-indent: -8.65pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2pt; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Total lease cost</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">211</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">416</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>

Supplemental cash flow information related to leases is as follows for the six months ended June 30, 2019:    <table cellspacing="0" cellpadding="0" style="width: 95%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td>Cash paid for amounts included in the measurement of lease liabilities:</td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; text-align: left">Operating cash outflow from operating leases</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">336</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term-finance leases (in years)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2.4</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Weighted-average remaining lease term-operating leases (in years)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3.5</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average discount rate-finance leases</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">9.1</td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Weighted-average discount rate-operating leases</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">14.4</td> <td style="text-align: left">%</td></tr> </table> The future maturities of the Company’s finance and operating leases as of June 30, 2019 is as follows:    <table cellspacing="0" cellpadding="0" style="width: 95%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Finance Leases</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Operating Leases</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">Total</td> <td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">2019</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">137</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">338</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">475</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2020</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">255</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">616</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">871</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2021</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">196</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">618</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">814</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2022</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">109</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">632</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">741</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2023</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">642</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">647</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">2024 and thereafter</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">580</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">580</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total payments</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">702</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">3,426</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">4,128</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left">Less amounts representing interest</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(85</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(1,059</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(1,144</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: left">Total minimum payments required:</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">617</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,367</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">2,984</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>

The revenues for the three months and six months ended June 30, 2019 and 2018, by category, are as follows:   <table cellspacing="0" cellpadding="0" style="width: 80%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="text-align: center">For the three months ended </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="text-align: center">For the six months ended</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">June 30</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">June 30</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold">Product Category</td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2019</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2018</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2019</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">2018</td> <td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Personal Care Ingredients</td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">2,151</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">2,923</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">4,160</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right">5,228</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Advanced Materials</td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">750</td> <td style="text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">742</td> <td style="text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,600</td> <td style="text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,274</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Solésence®</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">393</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">451</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">1,289</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">512</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: left">Total Sales</td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">3,294</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">4,116</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">7,049</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: black 2.5pt double; text-align: left">$</td> <td style="border-bottom: black 2.5pt double; text-align: right">7,014</td></tr> </table>

48600

(11) Share-Based Compensation   We follow FASB ASC Topic 718, Compensation – Stock Compensation, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $58 and $115 for the three and six months ended June 30, 2019, respectively, compared to $43 and $88 for the three and six months ended June 30, 2018, respectively.   As of June 30, 2019, there was approximately $486 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.0 years.   Stock Options and Stock Grants   During the six months ended June 30, 2019, 36,000 stock options were exercised for $16, while no stock options were exercised for the same period in 2018. During the six months ended June 30, 2019, 547,500 stock options were granted, compared to 570,500 stock options granted during the same period in 2018. During the six months ended June 30, 2019, 130,500 stock options expired compared to 188,504 for the same period in 2018. For the six months ended June 30, 2019, 48,600 stock options were forfeited compared to no stock options being forfeited for the same period in 2018. We had 3,747,400 stock options outstanding at a weighted average exercise price of $0.64 on June 30, 2019, compared to 3,415,000 stock options outstanding at a weighted average exercise price of $0.67 on December 31, 2018.    The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month and six month periods presented:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 95%; margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid">For the three months ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2019</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2018</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average risk-free interest rates:</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">2.5</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">2.9</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Dividend yield:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected life of the option:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected stock price volatility:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average fair value of the options granted:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.67</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.66</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid">For the six months ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2019</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2018</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average risk-free interest rates:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">2.5</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">2.9</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Dividend yield:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected life of the option:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected stock price volatility:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average fair value of the options granted:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.64</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.64</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>   As of June 30, 2019, we did not have any unvested restricted stock or performance shares outstanding.

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month and six month periods presented:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 95%; margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid">For the three months ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2019</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2018</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average risk-free interest rates:</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">2.5</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">2.9</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Dividend yield:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected life of the option:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected stock price volatility:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average fair value of the options granted:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.67</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.66</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid">For the six months ended</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2019</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">June 30, 2018</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average risk-free interest rates:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">2.5</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">2.9</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Dividend yield:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">—</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected life of the option:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">7 years</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average expected stock price volatility:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">94</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="text-align: left; padding-left: 0.25in; text-indent: -8.65pt; font: 10pt Times New Roman, Times, Serif">Weighted-average fair value of the options granted:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.64</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.64</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>

(14) Subsequent Events   On July 31, 2019, we entered into a Joint Development Agreement, with an initial term of ten years, with Sumitomo Corporation of Americas (“SCOA”) to jointly develop certain coated materials for the use in the personal care market. In return for the Company’s exclusive efforts on SCOA’s behalf, SCOA has agreed to pay a commitment fee of $250 and two subsequent payments, $125 each, in accordance with product development milestones expected to be earned over the next several years. Additionally, a royalty payment from the sale of the Joint Development Product will be paid to the Company.

125000

EX-101.SCH 6 nanx-20190630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited Consolidated Condensed) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited Consolidated Condensed) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited Consolidated Condensed) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern / Liquidity link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Revenues link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Notes and Line of Credit link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Significant Customers and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Business Segmentation and Geographical Distribution link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Lease (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Business Segmentation and Geographical Distribution (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Going Concern / Liquidity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Earnings Per Share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Notes and Line of Credit (Detail Narratives) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Lease (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Lease (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Lease (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Lease (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Significant Customers and Contingencies (Detail Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Business Segmentation and Geographical Distribution (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Subsequent Events (Detail Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 nanx-20190630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 nanx-20190630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 nanx-20190630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Short-term Debt, Type [Axis] Line of Credit [Member] Type of Arrangement and Non-arrangement Transactions [Axis] New Business Loan Agreement [Member] Business Loan Agreement [Member] Counterparty Name [Axis] Beachcorp, LLC [Member] Credit Facility [Axis] Asset-Based Revolving Loan Facility [Member] Libertyville [Member] Adjustments for New Accounting Pronouncements [Axis] Topic 842 [Member] Award Type [Axis] Stock Options [Member] Customer [Axis] Customers Three [Member] Supply Commitment [Axis] BASF [Member] Range [Axis] Less than [Member] Customers One [Member] Customers Two [Member] Greater than [Member] Product and Service [Axis] Personal Care Ingredients [Member] Advanced Materials [Member] Solesence [Member] Geographical [Axis] International Sources [Member] Product Revenue [Member] Other Revenue [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Joint Development Agreement [Member] Related Party Transaction [Axis] Sumitomo Corporation of Americas [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Document And Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Document Period End Date Entity File Number Entity Incorporation, State Code Current Fiscal Year End Date Entity Reporting Status Current Entity Interactive Data Current Entity Small Business Entity Filer Category Entity Emerging Growth Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash Trade accounts receivable, less allowance for doubtful accounts of $9 on June 30, 2019 and December 31, 2018, respectively Inventories, net Prepaid expenses and other current assets Total current assets Equipment and leasehold improvements, net Operating lease right-of-use assets Other assets, net Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Line of credit, related party Current portion of finance lease obligations Current portion of operating lease obligations Accounts payable Accrued expenses Total current liabilities Long-term portion of finance lease obligations Long-term portion of operating lease obligations Long-term loan, related party Long-term deferred rent Asset retirement obligations Total long-term liabilities Contingent liabilities: Stockholders' equity: Preferred stock, $.01 par value, 24,088 shares authorized, and no shares issued and outstanding Common stock, $.01 par value, 42,000,000 shares authorized; 38,100,792 shares issued and outstanding on June 30, 2019 and 33,911,792 December 31, 2018 Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Allowance for doubtful accounts Preferred stock, par value (in dollars per share) Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Common stock, par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Statement [Table] Statement [Line Items] Revenue: Total revenue Operating expense: Cost of revenue Gross profit Research and development expense Selling, general and administrative expense (Loss)/income from operations Interest expense Other, net (Loss)/income before provision for income taxes Provision for income taxes Net (loss)/income Net (loss)/income per basic shares (in dollars per share) Weighted average number of basic common shares outstanding (in shares) Net (loss)/income per diluted share (in dollars per share) Weighted average number of diluted common shares outstanding (in shares) Preferred Stock [Member] Balance at beginning Balance at beginning (in shares) Stock option exercises Stock option exercises (in shares) Stock-based compensation Issuance of Common Stock Issuance of Common Stock (in shares) Net loss Balance at ending Balance at ending (in shares) Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to cash used in operating activities: Depreciation and amortization Loss on disposal of equipment and leasehold improvements Share-based compensation Changes in assets and liabilities related to operations: Trade accounts receivable Inventories Prepaid expenses and other assets Accounts payable Accrued expenses Other long-term assets and liabilities Net cash used in operating activities Investing activities: Acquisition of equipment and leasehold improvements Net cash used in investing activities Financing activities: Principal payment on finance leases Proceeds from line of credit, bank Payments to the line of credit, bank Proceeds from line of credit, related party Payments to line of credit, related party Proceeds from issuance of common stock Proceeds from stock option exercises Net cash provided by financing activities Decrease in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental cash flow information: Interest paid Supplemental non-cash investing and financing activities: Accounts payable incurred for the purchase of equipment and leasehold improvements Non-cash purchases of property and equipment Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation Going Concern Liquidity Going Concern / Liquidity Accounting Policies [Abstract] Summary of Significant Accounting Policies Description Of Business Description of Business Revenue from Contract with Customer [Abstract] Revenues Earnings Per Share [Abstract] Earnings Per Share Fair Value Disclosures [Abstract] Financial Instruments Debt Disclosure [Abstract] Notes and Lines of Credit Inventory Disclosure [Abstract] Inventories Leases [Abstract] Leases Share-based Payment Arrangement [Abstract] Share-Based Compensation Risks and Uncertainties [Abstract] Significant Customers and Contingencies Segment Reporting [Abstract] EX-101.PRE 10 nanx-20190630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2019	Aug. 14, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	NANOPHASE TECHNOLOGIES Corp
Entity Central Index Key	0000883107
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2019
Entity File Number	000-22333
Entity Incorporation, State Code	DE
Current Fiscal Year End Date	--12-31
Entity Reporting Status Current	Yes
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		38,136,792
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash	$ 1,015	$ 1,345
Trade accounts receivable, less allowance for doubtful accounts of $9 on June 30, 2019 and December 31, 2018, respectively	1,652	829
Inventories, net	2,093	2,242
Prepaid expenses and other current assets	351	273
Total current assets	5,111	4,689
Equipment and leasehold improvements, net	2,127	1,865
Operating lease right-of-use assets	2,059
Other assets, net	14	15
Total assets	9,311	6,569
Current liabilities:
Line of credit, related party	1,246	832
Current portion of finance lease obligations	227	218
Current portion of operating lease obligations	329
Accounts payable	1,423	1,608
Accrued expenses	925	979
Total current liabilities	4,150	3,637
Long-term portion of finance lease obligations	390	506
Long-term portion of operating lease obligations	2,038
Long-term loan, related party	500	500
Long-term deferred rent		344
Asset retirement obligations	202	198
Total long-term liabilities	3,130	1,548
Stockholders' equity:
Preferred stock, $.01 par value, 24,088 shares authorized, and no shares issued and outstanding
Common stock, $.01 par value, 42,000,000 shares authorized; 38,100,792 shares issued and outstanding on June 30, 2019 and 33,911,792 December 31, 2018	381	339
Additional paid-in capital	100,560	98,795
Accumulated deficit	(98,910)	(97,750)
Total stockholders' equity	2,031	1,384
Total liabilities and stockholders' equity	$ 9,311	$ 6,569

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 9	$ 9
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized	24,088	24,088
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized	42,000,000	42,000,000
Common stock, issued	38,100,792	33,911,792
Common stock, outstanding	38,100,792	33,911,792

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited Consolidated Condensed) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenue:
Total revenue	$ 3,294	$ 4,116	$ 7,049	$ 7,014
Operating expense:
Cost of revenue	2,462	2,711	5,333	5,199
Gross profit	832	1,405	1,716	1,815
Research and development expense	485	538	962	1,096
Selling, general and administrative expense	944	770	1,821	1,535
(Loss)/income from operations	(597)	97	(1,067)	(816)
Interest expense	50	9	93	20
Other, net
(Loss)/income before provision for income taxes	(647)	88	(1,160)	(836)
Provision for income taxes
Net (loss)/income	$ (647)	$ 88	$ (1,160)	$ (836)
Net (loss)/income per basic shares (in dollars per share)	$ (0.02)	$ 0	$ (0.03)	$ (0.02)
Weighted average number of basic common shares outstanding (in shares)	36,136,759	33,847,793	35,030,422	33,847,793
Net (loss)/income per diluted share (in dollars per share)	$ (0.02)	$ 0	$ (0.03)	$ (0.02)
Weighted average number of diluted common shares outstanding (in shares)	36,136,759	34,909,793	35,030,422	33,847,793
Product Revenue [Member]
Revenue:
Total revenue	$ 3,257	$ 4,043	$ 6,754	$ 6,910
Other Revenue [Member]
Revenue:
Total revenue	$ 37	$ 73	$ 295	$ 104

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited Consolidated Condensed) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at beginning at Dec. 31, 2017	$ 338	$ 98,563	$ (95,669)	$ 3,232
Balance at beginning (in shares) at Dec. 31, 2017	33,847,793
Stock-based compensation		43		43
Net loss			(924)	(924)
Balance at ending at Mar. 31, 2018	$ 338	98,606	(96,593)	2,351
Balance at ending (in shares) at Mar. 31, 2018	33,847,793
Balance at beginning at Dec. 31, 2017	$ 338	98,563	(95,669)	3,232
Balance at beginning (in shares) at Dec. 31, 2017	33,847,793
Net loss				(836)
Balance at ending at Jun. 30, 2018	$ 338	98,651	(96,505)	2,484
Balance at ending (in shares) at Jun. 30, 2018	33,847,793
Balance at beginning at Mar. 31, 2018	$ 338	98,606	(96,593)	2,351
Balance at beginning (in shares) at Mar. 31, 2018	33,847,793
Stock-based compensation		45		45
Net loss			88	88
Balance at ending at Jun. 30, 2018	$ 338	98,651	(96,505)	2,484
Balance at ending (in shares) at Jun. 30, 2018	33,847,793
Balance at beginning at Dec. 31, 2018	$ 339	98,795	(97,750)	1,384
Balance at beginning (in shares) at Dec. 31, 2018	33,911,792
Stock-based compensation		57		57
Net loss			(513)	(513)
Balance at ending at Mar. 31, 2019	$ 339	98,852	(98,263)	928
Balance at ending (in shares) at Mar. 31, 2019	33,911,792
Balance at beginning at Dec. 31, 2018	$ 339	98,795	(97,750)	1,384
Balance at beginning (in shares) at Dec. 31, 2018	33,911,792
Net loss				(1,160)
Balance at ending at Jun. 30, 2019	$ 381	100,560	(98,910)	2,031
Balance at ending (in shares) at Jun. 30, 2019	38,136,792
Balance at beginning at Mar. 31, 2019	$ 339	98,852	(98,263)	928
Balance at beginning (in shares) at Mar. 31, 2019	33,911,792
Stock option exercises		16		16
Stock option exercises (in shares)	36,000
Stock-based compensation		58		58
Issuance of Common Stock	$ 42	1,634		1,676
Issuance of Common Stock (in shares)	4,189,000
Net loss			(647)	(647)
Balance at ending at Jun. 30, 2019	$ 381	$ 100,560	$ (98,910)	$ 2,031
Balance at ending (in shares) at Jun. 30, 2019	38,136,792

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 16 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited Consolidated Condensed) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Operating activities:
Net loss	$ (1,160)	$ (836)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	155	166
Loss on disposal of equipment and leasehold improvements	16
Share-based compensation	115	88
Changes in assets and liabilities related to operations:
Trade accounts receivable	(823)	(313)
Inventories	149	(264)
Prepaid expenses and other assets	(78)	(109)
Accounts payable	(224)	563
Accrued expenses	(54)	102
Other long-term assets and liabilities	(36)
Net cash used in operating activities	(1,940)	(603)
Investing activities:
Acquisition of equipment and leasehold improvements	(389)	(132)
Net cash used in investing activities	(389)	(132)
Financing activities:
Principal payment on finance leases	(107)	(79)
Proceeds from line of credit, bank	500	700
Payments to the line of credit, bank	(500)	(500)
Proceeds from line of credit, related party	5,846
Payments to line of credit, related party	(5,432)
Proceeds from issuance of common stock	1,676
Proceeds from stock option exercises	16
Net cash provided by financing activities	1,999	121
Decrease in cash and cash equivalents	(330)	(614)
Cash and cash equivalents at beginning of period	1,345	1,955
Cash and cash equivalents at end of period	1,015	1,341
Supplemental cash flow information:
Interest paid	86	20
Supplemental non-cash investing and financing activities:
Accounts payable incurred for the purchase of equipment and leasehold improvements	$ 39	8
Non-cash purchases of property and equipment		$ 45

XML 17 R7.htm IDEA: XBRL DOCUMENT

Basis of Presentation

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

(1) Basis of Presentation

XML 18 R8.htm IDEA: XBRL DOCUMENT

Going Concern / Liquidity

6 Months Ended

Jun. 30, 2019

Going Concern Liquidity

Going Concern / Liquidity

(2) Going Concern / Liquidity

XML 19 R9.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

(3) Summary of Significant Accounting Policies

Recently Adopted Financial Accounting Standards

XML 20 R10.htm IDEA: XBRL DOCUMENT

Description of Business

6 Months Ended

Jun. 30, 2019

Description Of Business

Description of Business

(4) Description of Business

XML 21 R11.htm IDEA: XBRL DOCUMENT

Revenues

6 Months Ended

Jun. 30, 2019

Revenue from Contract with Customer [Abstract]

Revenues

(5) Revenues

XML 22 R12.htm IDEA: XBRL DOCUMENT

Earnings Per Share

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share

(6) Earnings Per Share

XML 23 R13.htm IDEA: XBRL DOCUMENT

Financial Instruments

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Financial Instruments

(7) Financial Instruments

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 24 R14.htm IDEA: XBRL DOCUMENT

Notes and Line of Credit

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Notes and Lines of Credit

(8) Notes and Line of Credit

XML 25 R15.htm IDEA: XBRL DOCUMENT

Inventories

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Inventories

(9) Inventories

Inventories consist of the following:

	June 30, 2019			December 31, 2018

Raw materials	$	1,118		$	1,086
Finished goods		1,041			1,243
		2,159			2,329
Allowance for excess inventory quantities		(66	)		(87	)
	$	2,093		$	2,242

XML 26 R16.htm IDEA: XBRL DOCUMENT

Leases

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Leases

(10) Leases

Quantitative information regarding the Company’s leases is as follows:

	Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Components of lease cost
Finance lease cost components:
Amortization of finance lease assets	$	17	$	34
Interest on finance lease liabilities		14		30
Total finance lease costs		31		64
Operating lease cost components:
Operating lease cost		123		246
Variable lease cost		27		54
Short-term lease cost		30		52
Total operating lease costs		180		352

Total lease cost	$	211	$	416

Supplemental cash flow information related to leases is as follows for the six months ended June 30, 2019:

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflow from operating leases	$	336

Weighted-average remaining lease term-finance leases (in years)		2.4
Weighted-average remaining lease term-operating leases (in years)		3.5
Weighted-average discount rate-finance leases		9.1	%
Weighted-average discount rate-operating leases		14.4	%

The future maturities of the Company’s finance and operating leases as of June 30, 2019 is as follows:

	Finance Leases			Operating Leases			Total
2019	$	137		$	338		$	475
2020		255			616			871
2021		196			618			814
2022		109			632			741
2023		5			642			647
2024 and thereafter		—			580			580
Total payments	$	702		$	3,426		$	4,128
Less amounts representing interest		(85	)		(1,059	)		(1,144	)
Total minimum payments required:	$	617		$	2,367		$	2,984

XML 27 R17.htm IDEA: XBRL DOCUMENT

Share-Based Compensation

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Share-Based Compensation

(11) Share-Based Compensation

Stock Options and Stock Grants

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month and six month periods presented:

For the three months ended	June 30, 2019			June 30, 2018
Weighted-average risk-free interest rates:		2.5	%		2.9	%
Dividend yield:		—			—
Weighted-average expected life of the option:		7 years			7 years
Weighted-average expected stock price volatility:		94	%		94	%
Weighted-average fair value of the options granted:	$	0.67		$	0.66

For the six months ended	June 30, 2019			June 30, 2018
Weighted-average risk-free interest rates:		2.5	%		2.9	%
Dividend yield:		—			—
Weighted-average expected life of the option:		7 years			7 years
Weighted-average expected stock price volatility:		94	%		94	%
Weighted-average fair value of the options granted:	$	0.64		$	0.64

As of June 30, 2019, we did not have any unvested restricted stock or performance shares outstanding.

XML 28 R18.htm IDEA: XBRL DOCUMENT

Significant Customers and Contingencies

6 Months Ended

Jun. 30, 2019

Risks and Uncertainties [Abstract]

Significant Customers and Contingencies

(12) Significant Customers and Contingencies

XML 29 R19.htm IDEA: XBRL DOCUMENT

Business Segmentation and Geographical Distribution

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Business Segmentation and Geographical Distribution

(13) Business Segmentation and Geographical Distribution

	For the three months ended				For the six months ended
	June 30				June 30
Product Category	2019		2018		2019		2018
Personal Care Ingredients	$	2,151	$	2,923	$	4,160	$	5,228
Advanced Materials		750		742		1,600		1,274
Solésence^®		393		451		1,289		512
Total Sales	$	3,294	$	4,116	$	7,049	$	7,014

XML 30 R20.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2019

Subsequent Events [Abstract]

Subsequent Events

(14) Subsequent Events

XML 31 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Recently Adopted Financial Accounting Standards

Recently Adopted Financial Accounting Standards

XML 32 R22.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Schedule of inventories

Inventories consist of the following:

	June 30, 2019			December 31, 2018

Raw materials	$	1,118		$	1,086
Finished goods		1,041			1,243
		2,159			2,329
Allowance for excess inventory quantities		(66	)		(87	)
	$	2,093		$	2,242

XML 33 R23.htm IDEA: XBRL DOCUMENT

Lease (Tables)

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Summary of information regarding leases

Quantitative information regarding the Company’s leases is as follows:

	Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Components of lease cost
Finance lease cost components:
Amortization of finance lease assets	$	17	$	34
Interest on finance lease liabilities		14		30
Total finance lease costs		31		64
Operating lease cost components:
Operating lease cost		123		246
Variable lease cost		27		54
Short-term lease cost		30		52
Total operating lease costs		180		352

Total lease cost	$	211	$	416

Summary of supplemental cash flow information related to leases

Supplemental cash flow information related to leases is as follows for the six months ended June 30, 2019:

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflow from operating leases	$	336

Weighted-average remaining lease term-finance leases (in years)		2.4
Weighted-average remaining lease term-operating leases (in years)		3.5
Weighted-average discount rate-finance leases		9.1	%
Weighted-average discount rate-operating leases		14.4	%

Schedule of future maturities of finance and operating leases

The future maturities of the Company’s finance and operating leases as of June 30, 2019 is as follows:

	Finance Leases			Operating Leases			Total
2019	$	137		$	338		$	475
2020		255			616			871
2021		196			618			814
2022		109			632			741
2023		5			642			647
2024 and thereafter		—			580			580
Total payments	$	702		$	3,426		$	4,128
Less amounts representing interest		(85	)		(1,059	)		(1,144	)
Total minimum payments required:	$	617		$	2,367		$	2,984

XML 34 R24.htm IDEA: XBRL DOCUMENT

Share-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Schedule of assumptions used to calculate black-scholes option pricing model for options granted

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the three month and six month periods presented:

For the three months ended	June 30, 2019			June 30, 2018
Weighted-average risk-free interest rates:		2.5	%		2.9	%
Dividend yield:		—			—
Weighted-average expected life of the option:		7 years			7 years
Weighted-average expected stock price volatility:		94	%		94	%
Weighted-average fair value of the options granted:	$	0.67		$	0.66

For the six months ended	June 30, 2019			June 30, 2018
Weighted-average risk-free interest rates:		2.5	%		2.9	%
Dividend yield:		—			—
Weighted-average expected life of the option:		7 years			7 years
Weighted-average expected stock price volatility:		94	%		94	%
Weighted-average fair value of the options granted:	$	0.64		$	0.64

XML 35 R25.htm IDEA: XBRL DOCUMENT

Business Segmentation and Geographical Distribution (Tables)

6 Months Ended

Jun. 30, 2019

Segments, Geographical Areas [Abstract]

Schedule of revenue by category

The revenues for the three months and six months ended June 30, 2019 and 2018, by category, are as follows:

	For the three months ended				For the six months ended
	June 30				June 30
Product Category	2019		2018		2019		2018
Personal Care Ingredients	$	2,151	$	2,923	$	4,160	$	5,228
Advanced Materials		750		742		1,600		1,274
Solésence^®		393		451		1,289		512
Total Sales	$	3,294	$	4,116	$	7,049	$	7,014

XML 36 R26.htm IDEA: XBRL DOCUMENT

Going Concern / Liquidity (Details Narrative)	6 Months Ended
Going Concern / Liquidity (Details Narrative)	Jun. 30, 2018
Customer Concentration Risk [Member] \| Revenue Benchmark [Member]
Concentration risk, percentage	74.00%

XML 37 R27.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Details Narrative) - $ / shares	3 Months Ended		6 Months Ended
Earnings Per Share (Details Narrative) - $ / shares	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Earnings Per Share [Abstract]
Antidilutive securities	409,000	1,062,000	671,000	681,000
Net loss per share-basic and diluted (in dollar per share)		$ 0.00

XML 38 R28.htm IDEA: XBRL DOCUMENT

Notes and Line of Credit (Detail Narratives) $ in Thousands			3 Months Ended		6 Months Ended
Notes and Line of Credit (Detail Narratives) $ in Thousands	Mar. 22, 2019 USD ($) Number	Nov. 16, 2018 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Dec. 31, 2018 USD ($)
Line of credit, related party			$ 1,246		$ 1,246		$ 832
Beachcorp, LLC [Member]
Interest expenses					59
Business Loan Agreement [Member] \| Beachcorp, LLC [Member]
Line of credit facility, maximum borrowing capacity			345		345
Line of Credit		$ 86
Line of credit, related party		1,246
Interest expenses			50	$ 9	93	$ 20
Term loan		$ 500
Fixed annual interest rate		8.25%
Maturity date		Dec. 31, 2020
Ownership percentage		53.00%
Term loan collateral		The Term Loan and Revolver Facility are secured by all the unencumbered assets of the Company and subordinated to Libertyville’s secured interest under the New Business Loan Agreement.
Accrued expenses					7
Business Loan Agreement [Member] \| Beachcorp, LLC [Member] \| Asset-Based Revolving Loan Facility [Member]
Basis spread variable interest rate		3.00%
Variable interest rate basis		Prime rate
Line of credit facility, maximum borrowing capacity		$ 2
Facility, expiration date		Mar. 31, 2020
Line of Credit [Member] \| New Business Loan Agreement [Member]
Basis spread variable interest rate	1.00%
Variable interest rate basis	Prime rate
Line of credit facility, maximum borrowing capacity	$ 500
Borrowing capacity as percentage of accounts receivable	75.00%
Borrowing capacity as multiple of accounts receivable \| Number	2
Minimum amount of cash on hand before advance is given	$ 500
Facility, expiration date	Apr. 04, 2020
Line of Credit			0		0		$ 0
Line of Credit [Member] \| Business Loan Agreement [Member] \| Libertyville [Member]
Line of Credit			$ 300		$ 300

XML 39 R29.htm IDEA: XBRL DOCUMENT

Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 1,118	$ 1,086
Finished goods	1,041	1,243
Inventory gross, Total	2,159	2,329
Allowance for excess quantities	(66)	(87)
Total inventory	$ 2,093	$ 2,242

XML 40 R30.htm IDEA: XBRL DOCUMENT

Lease (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Lease (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Jun. 30, 2019
Finance lease cost components:
Amortization of finance lease assets	$ 17	$ 34
Interest on finance lease liabilities	14	30
Total finance lease costs	31	64
Operating lease cost components:
Operating lease cost	123	246
Variable lease cost	27	54
Short-term lease cost	30	52
Total operating lease costs	180	352
Total lease cost	$ 211	$ 416

XML 41 R31.htm IDEA: XBRL DOCUMENT

Lease (Details 1) $ in Thousands	6 Months Ended
Lease (Details 1) $ in Thousands	Jun. 30, 2019 USD ($)
Cash paid for amounts included in the measurement of lease liabiltiies:
Operating cash outflow from operating leases	$ 336
Weighted-average remaining lease term-finance leases (in years)	2 years 4 months 24 days
Weighted-average remaining lease term-operating leases (in years)	3 years 6 months
Weighted-average discount rate-finance leases	9.10%
Weighted-average discount rate-operating leases	14.40%

XML 42 R32.htm IDEA: XBRL DOCUMENT

Lease (Details 2) $ in Thousands	Jun. 30, 2019 USD ($)
Operating Leases:
2019	$ 338
2020	616
2021	618
2022	632
2023	642
2024 and thereafter	580
Total payments	3,426
Less amounts representing interest	(1,059)
Total minimum payments required	2,367
Finance Leases:
2019	137
2020	255
2021	196
2022	109
2023	5
2024 and thereafter
Total payments	702
Less amounts representing interest	(85)
Total minimum payments required	617
Total:
2019	475
2020	871
2021	814
2022	741
2023	647
2024 and thereafter	580
Total payments	4,128
Less amounts representing interest	(1,144)
Total minimum payments required	$ 2,984

XML 43 R33.htm IDEA: XBRL DOCUMENT

Lease (Details Narrative) - USD ($) $ in Thousands	Jun. 30, 2019	Jan. 02, 2019
Operating Leased Assets [Line Items]
Operating lease right-of-use assets	$ 2,059
Current portion of operating lease obligations	329
Long-term portion of operating lease obligations	2,038
Operating lease liability	$ 2,367
Topic 842 [Member]
Operating Leased Assets [Line Items]
Operating lease right-of-use assets		$ 2,212
Operating lease liability		$ 2,556

XML 44 R34.htm IDEA: XBRL DOCUMENT

Share-Based Compensation (Details) - Stock Options [Member] - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Weighted-average risk-free interest rates	2.50%	2.90%	2.50%	2.90%
Dividend yield	0.00%	0.00%	0.00%	0.00%
Weighted-average expected life of the option	7 years	7 years	7 years	7 years
Weighted-average expected stock price volatility	94.00%	94.00%	94.00%	94.00%
Weighted-average fair value of the options granted	$ 0.67	$ 0.66	$ 0.64	$ 0.64

XML 45 R35.htm IDEA: XBRL DOCUMENT

Share-Based Compensation (Detail Narratives) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted	$ 486		$ 486
Weighted-average period over which unrecognized compensation is expected to be recognized			2 years
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 58	$ 43	$ 115	$ 88
Stock options granted			547,500	570,500
Stock options excercise			36,000	0
Stock option excercise value	$ 16		$ 16
Stock options expired			130,500	188,504
Stock options forfeited			48,600
Stock options outstanding, end of period	3,747,400		3,747,400		3,415,000
Weighted average exercise price	$ 0.64		$ 0.64		$ 0.67

XML 46 R36.htm IDEA: XBRL DOCUMENT

Significant Customers and Contingencies (Detail Narrative) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) Number	Jun. 30, 2018 USD ($)	Sep. 30, 2019 USD ($)	Dec. 31, 2018 USD ($)
Number of major customers \| Number			3
Accounts receivable	$ 1,652		$ 1,652
Cash, cash equivalents and investments trigger under supply agreeement	500		500
Finished goods inventory	1,041		1,041			$ 1,243
BASF [Member] \| Less than [Member]
Earnings trigger under supply agreeement			0
BASF [Member] \| Greater than [Member]
Cash, cash equivalents and investments trigger under supply agreeement	1,000		1,000		$ 1,000
Accelerated debt maturity - principal amount debt	10,000		10,000
Finished goods inventory	500		500
Customers One [Member]
Accounts receivable	843	$ 927	843	$ 927
Customers Two [Member]
Accounts receivable	212	54	212	54
Customers Three [Member]
Accounts receivable	$ 93	$ 76	$ 93	$ 76
Customer Concentration Risk [Member] \| Revenue Benchmark [Member]
Revenue from customers				74.00%
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Customers One [Member]
Revenue from customers	65.00%	66.00%	59.00%	73.00%
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Customers Two [Member]
Revenue from customers	5.00%	10.00%	12.00%	6.00%
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Customers Three [Member]
Revenue from customers	4.00%	4.00%	3.00%	3.00%

XML 47 R37.htm IDEA: XBRL DOCUMENT

Business Segmentation and Geographical Distribution (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Sales	$ 3,294	$ 4,116	$ 7,049	$ 7,014
Personal Care Ingredients [Member]
Sales	2,151	2,923	4,160	5,228
Advanced Materials [Member]
Sales	750	742	1,600	1,274
Solesence [Member]
Sales	$ 393	$ 451	$ 1,289	$ 512

XML 48 R38.htm IDEA: XBRL DOCUMENT

Business Segmentation and Geographical Distribution (Detail Narratives) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) Number	Jun. 30, 2018 USD ($)
Number of business segments \| Number			1
International Sources [Member]
Revenue from international sources \| $	$ 243	$ 164	$ 700	$ 183

XML 49 R39.htm IDEA: XBRL DOCUMENT

Subsequent Events (Detail Narrative) - Subsequent Event [Member] - Joint Development Agreement [Member] - Sumitomo Corporation of Americas [Member] $ in Thousands	1 Months Ended
	Jul. 31, 2019 USD ($)
Commitment fee	$ 250
Agreement term	10 years
Commitment fee payable	$ 125

EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 110 284 1 false 28 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://nanophase.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) Sheet http://nanophase.com/role/ConsolidatedBalanceSheetsUnauditedConsolidatedCondensed CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) (Parenthetical) Sheet http://nanophase.com/role/ConsolidatedBalanceSheetsUnauditedConsolidatedCondensedParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited Consolidated Condensed) Sheet http://nanophase.com/role/ConsolidatedStatementsOfOperationsUnauditedConsolidatedCondensed CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited Consolidated Condensed) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited Consolidated Condensed) Sheet http://nanophase.com/role/ConsolidatedStatementsOfShareholdersEquityUnauditedConsolidatedCondensed CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited Consolidated Condensed) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited Consolidated Condensed) Sheet http://nanophase.com/role/ConsolidatedStatementsOfCashFlowsUnauditedConsolidatedCondensed CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited Consolidated Condensed) Statements 6 false false R7.htm 00000007 - Disclosure - Basis of Presentation Sheet http://nanophase.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern / Liquidity Sheet http://nanophase.com/role/GoingConcernLiquidity Going Concern / Liquidity Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://nanophase.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Description of Business Sheet http://nanophase.com/role/DescriptionOfBusiness Description of Business Notes 10 false false R11.htm 00000011 - Disclosure - Revenues Sheet http://nanophase.com/role/Revenues Revenues Notes 11 false false R12.htm 00000012 - Disclosure - Earnings Per Share Sheet http://nanophase.com/role/EarningsPerShare Earnings Per Share Notes 12 false false R13.htm 00000013 - Disclosure - Financial Instruments Sheet http://nanophase.com/role/FinancialInstruments Financial Instruments Notes 13 false false R14.htm 00000014 - Disclosure - Notes and Line of Credit Notes http://nanophase.com/role/NotesAndLineOfCredit Notes and Line of Credit Notes 14 false false R15.htm 00000015 - Disclosure - Inventories Sheet http://nanophase.com/role/Inventories Inventories Notes 15 false false R16.htm 00000016 - Disclosure - Leases Sheet http://nanophase.com/role/Leases Leases Notes 16 false false R17.htm 00000017 - Disclosure - Share-Based Compensation Sheet http://nanophase.com/role/Share-basedCompensation Share-Based Compensation Notes 17 false false R18.htm 00000018 - Disclosure - Significant Customers and Contingencies Sheet http://nanophase.com/role/SignificantCustomersAndContingencies Significant Customers and Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Business Segmentation and Geographical Distribution Sheet http://nanophase.com/role/BusinessSegmentationAndGeographicalDistribution Business Segmentation and Geographical Distribution Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://nanophase.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://nanophase.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Inventories (Tables) Sheet http://nanophase.com/role/InventoriesTables Inventories (Tables) Tables http://nanophase.com/role/Inventories 22 false false R23.htm 00000023 - Disclosure - Lease (Tables) Sheet http://nanophase.com/role/LeaseTables Lease (Tables) Tables http://nanophase.com/role/Leases 23 false false R24.htm 00000024 - Disclosure - Share-Based Compensation (Tables) Sheet http://nanophase.com/role/Share-basedCompensationTables Share-Based Compensation (Tables) Tables http://nanophase.com/role/Share-basedCompensation 24 false false R25.htm 00000025 - Disclosure - Business Segmentation and Geographical Distribution (Tables) Sheet http://nanophase.com/role/BusinessSegmentationAndGeographicalDistributionTables Business Segmentation and Geographical Distribution (Tables) Tables http://nanophase.com/role/BusinessSegmentationAndGeographicalDistribution 25 false false R26.htm 00000026 - Disclosure - Going Concern / Liquidity (Details Narrative) Sheet http://nanophase.com/role/GoingConcernLiquidityDetailsNarrative Going Concern / Liquidity (Details Narrative) Details http://nanophase.com/role/GoingConcernLiquidity 26 false false R27.htm 00000027 - Disclosure - Earnings Per Share (Details Narrative) Sheet http://nanophase.com/role/EarningsPerShareDetailsNarrative Earnings Per Share (Details Narrative) Details http://nanophase.com/role/EarningsPerShare 27 false false R28.htm 00000028 - Disclosure - Notes and Line of Credit (Detail Narratives) Notes http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives Notes and Line of Credit (Detail Narratives) Details http://nanophase.com/role/NotesAndLineOfCredit 28 false false R29.htm 00000029 - Disclosure - Inventories (Details) Sheet http://nanophase.com/role/InventoriesDetails Inventories (Details) Details http://nanophase.com/role/InventoriesTables 29 false false R30.htm 00000030 - Disclosure - Lease (Details) Sheet http://nanophase.com/role/LeaseDetails Lease (Details) Details http://nanophase.com/role/LeaseTables 30 false false R31.htm 00000031 - Disclosure - Lease (Details 1) Sheet http://nanophase.com/role/LeaseDetails1 Lease (Details 1) Details http://nanophase.com/role/LeaseTables 31 false false R32.htm 00000032 - Disclosure - Lease (Details 2) Sheet http://nanophase.com/role/LeaseDetails2 Lease (Details 2) Details http://nanophase.com/role/LeaseTables 32 false false R33.htm 00000033 - Disclosure - Lease (Details Narrative) Sheet http://nanophase.com/role/LeaseDetailsNarrative Lease (Details Narrative) Details http://nanophase.com/role/LeaseTables 33 false false R34.htm 00000034 - Disclosure - Share-Based Compensation (Details) Sheet http://nanophase.com/role/Share-basedCompensationDetails Share-Based Compensation (Details) Details http://nanophase.com/role/Share-basedCompensationTables 34 false false R35.htm 00000035 - Disclosure - Share-Based Compensation (Detail Narratives) Sheet http://nanophase.com/role/Share-basedCompensationDetailNarratives Share-Based Compensation (Detail Narratives) Details http://nanophase.com/role/Share-basedCompensationTables 35 false false R36.htm 00000036 - Disclosure - Significant Customers and Contingencies (Detail Narrative) Sheet http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives Significant Customers and Contingencies (Detail Narrative) Details http://nanophase.com/role/SignificantCustomersAndContingencies 36 false false R37.htm 00000037 - Disclosure - Business Segmentation and Geographical Distribution (Details) Sheet http://nanophase.com/role/BusinessSegmentationAndGeographicalDistributionDetails Business Segmentation and Geographical Distribution (Details) Details http://nanophase.com/role/BusinessSegmentationAndGeographicalDistributionTables 37 false false R38.htm 00000038 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives) Sheet http://nanophase.com/role/BusinessSegmentationAndGeographicalDistributionDetailNarratives Business Segmentation and Geographical Distribution (Detail Narratives) Details http://nanophase.com/role/BusinessSegmentationAndGeographicalDistributionTables 38 false false R39.htm 00000039 - Disclosure - Subsequent Events (Detail Narrative) Sheet http://nanophase.com/role/SubsequentEventsDetailNarrative Subsequent Events (Detail Narrative) Details http://nanophase.com/role/SubsequentEvents 39 false false All Reports Book All Reports nanx-20190630.xml nanx-20190630.xsd nanx-20190630_cal.xml nanx-20190630_def.xml nanx-20190630_lab.xml nanx-20190630_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true ZIP 55 0001387131-19-006135-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001387131-19-006135-xbrl.zip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end